Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD)

Angela T Burge, Narelle S Cox, Michael J Abramson, Anne E Holland, Angela T Burge, Narelle S Cox, Michael J Abramson, Anne E Holland

Abstract

Background: Escalating awareness of the magnitude of the challenge posed by low levels of physical activity in people with chronic obstructive pulmonary disease (COPD) highlights the need for interventions to increase physical activity participation. The widely-accepted benefits of physical activity, coupled with the increasing availability of wearable monitoring devices to objectively measure participation, has led to a dramatic rise in the number and variety of studies that aimed to improve the physical activity of people with COPD. However, little was known about the relative efficacy of interventions tested so far.

Objectives: In people with COPD, which interventions are effective at improving objectively-assessed physical activity?

Search methods: We identified trials from the Cochrane Airways Trials Register Register, which contains records identified from bibliographic databases including the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, CINAHL, AMED, and PsycINFO. We also searched PEDro, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform portal and the Australian New Zealand Clinical Trials Registry (from inception to June 2019). We checked reference lists of all primary studies and review articles for additional references, as well as respiratory journals and respiratory meeting abstracts, to identify relevant studies.

Selection criteria: We included randomised controlled trials of interventions that used objective measures for the assessment of physical activity in people with COPD. Trials compared an intervention with no intervention or a sham/placebo intervention, an intervention in addition to another standard intervention common to both groups, or two different interventions.

Data collection and analysis: We used standard methods recommended by Cochrane. Subgroup analyses were possible for supervised compared to unsupervised pulmonary rehabilitation programmes in clinically-stable COPD for a range of physical activity outcomes. Secondary outcomes were health-related quality of life, exercise capacity, adverse events and adherence. Insufficient data were available to perform prespecified subgroup analyses by duration of intervention or disease severity. We undertook sensitivity analyses by removing studies that were at high or unclear risk of bias for the domains of blinding and incomplete outcome data.

Main results: We included 76 studies with 8018 participants. Most studies were funded by government bodies, although some were sponsored by equipment or drug manufacturers. Only 38 studies had physical activity as a primary outcome. A diverse range of interventions have been assessed, primarily in single studies, but improvements have not been systematically demonstrated following any particular interventions. Where improvements were demonstrated, results were confined to single studies, or data for maintained improvement were not provided. Step count was the most frequently reported outcome, but it was commonly assessed using devices with documented inaccuracy for this variable. Compared to no intervention, the mean difference (MD) in time in moderate- to vigorous-intensity physical activity (MVPA) following pulmonary rehabilitation was four minutes per day (95% confidence interval (CI) -2 to 9; 3 studies, 190 participants; low-certainty evidence). An improvement was demonstrated following high-intensity interval exercise training (6 minutes per day, 95% CI 4 to 8; 2 studies, 275 participants; moderate-certainty evidence). One study demonstrated an improvement following six months of physical activity counselling (MD 11 minutes per day, 95% CI 7 to 15; 1 study, 280 participants; moderate-certainty evidence), but we found mixed results for the addition of physical activity counselling to pulmonary rehabilitation. There was an improvement following three to four weeks of pharmacological treatment with long-acting muscarinic antagonist and long-acting beta2-agonist (LAMA/LABA) compared to placebo (MD 10 minutes per day, 95% CI 4 to 15; 2 studies, 423 participants; high-certainty evidence). These interventions also demonstrated improvements in other measures of physical activity. Other interventions included self-management strategies, nutritional supplementation, supplemental oxygen, endobronchial valve surgery, non-invasive ventilation, neuromuscular electrical stimulation and inspiratory muscle training.

Authors' conclusions: A diverse range of interventions have been assessed, primarily in single studies. Improvements in physical activity have not been systematically demonstrated following any particular intervention. There was limited evidence for improvement in physical activity with strategies including exercise training, physical activity counselling and pharmacological management. The optimal timing, components, duration and models for interventions are still unclear. Assessment of quality was limited by a lack of methodological detail. There was scant evidence for a continued effect over time following completion of interventions, a likely requirement for meaningful health benefits for people with COPD.

Conflict of interest statement

Angela Burge received a PhD stipend from the National Health and Medical Research Council (NHMRC), Australia. This Cochrane Review forms a part of those PhD studies. The National Health and Medical Research Council (NHMRC) supports the independent conduct and publication of this Cochrane Review.

Narelle Cox is the holder of a NHMRC Early Career Fellowship. She presented workshops relating to pulmonary rehabilitation at the 2018 National General Practitioners Meeting sponsored by Boeringher Ingelheim.

Michael Abramson holds investigator‐initiated grants from Pfizer and Boehringer‐Ingelheim for unrelated research, undertook unrelated consultancies for AstraZeneca and Sanofi, and received assistance with conference attendance from Boehringer‐Ingelheim and Sanofi.

Anne Holland has received fees from AstraZeneca and Boehringer Ingelheim for non‐promotional speaking engagements (unrelated to the present work).

Three review authors (AB, NC and AH) were co‐authors on an included study (Holland 2017), so an independent co‐author (MA) undertook the assessment of risks of bias.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.1: Physical activity: change in step count (steps per day)
4
4
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.2: Physical activity: change in time in moderate‐to‐vigorous intensity physical activity (minutes per day)
5
5
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.4: Physical activity: change in time in light‐intensity physical activity (minutes per day)
6
6
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.3: Physical activity: change in total energy expenditure (kcal)
7
7
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.6: Physical activity: change in time in physical activity (total, minutes per day)
8
8
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.5: Physical activity: change in sedentary time (minutes per day)
9
9
Forest plot of comparison 1: Intervention vs. no intervention Outcome: 1.8 Physical activity: time in "lifestyle" physical activity (minutes per day)
10
10
Forest plot of comparison: 1 Intervention vs. no intervention Outcome: 1.7 Physical activity: time in light‐intensity physical activity (minutes per day)
11
11
Forest plot of comparison 1: Intervention vs. vs. no intervention Outcome 1.9: Physical activity: time in MVPA (minutes per day)
12
12
Forest plot of comparison 1: Intervention vs. no intervention Outcome 1.10: Physical activity: sedentary time (minutes per day)
13
13
Forest plot of comparison 2: Intervention vs. placebo Outcome 2.2: Physical activity: change in step count (steps per day)
14
14
Forest plot of comparison 2: Intervention vs. placebo Outcome 2.3: Physical activity: change in time in moderate‐to‐vigorous intensity physical activity (minutes per day)
15
15
Forest plot of comparison 2: Intervention vs. placebo Outcome 2.4: Physical activity: change in active energy expenditure (kcal)
1.1. Analysis
1.1. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 1 change in step count (steps per day); Intervention: pulmonary rehabilitation/exercise training.
1.2. Analysis
1.2. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 2 time/change in time in moderate‐to‐vigorous intensity physical activity (minutes per day); Intervention: pulmonary rehabilitation/exercise training.
1.3. Analysis
1.3. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 3 change in time in light‐intensity physical activity (minutes per day); Intervention: pulmonary rehabilitation/exercise training.
1.4. Analysis
1.4. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 4 change in total energy expenditure (kcal); Intervention: pulmonary rehabilitation/exercise training.
1.5. Analysis
1.5. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 5 change in time in physical activity (total; minutes per day); Intervention: pulmonary rehabilitation/exercise training.
1.6. Analysis
1.6. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 6 change in sedentary time (minutes per day); Intervention: pulmonary rehabilitation/exercise training.
1.7. Analysis
1.7. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 7 time in "lifestyle" physical activity (minutes per day); Intervention: high‐intensity interval training.
1.8. Analysis
1.8. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 8 time in light‐intensity physical activity (minutes per day); Intervention: high‐intensity interval training.
1.9. Analysis
1.9. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 9 time in moderate‐to‐vigorous intensity physical activity (minutes per day); Intervention: high‐intensity interval training.
1.10. Analysis
1.10. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 10 sedentary time (minutes per day); Intervention: high‐intensity interval training.
1.11. Analysis
1.11. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 11 step count (steps per day); Intervention: physical activity counselling.
1.12. Analysis
1.12. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 12 "IMA" (counts per minute); Intervention: self‐management.
1.13. Analysis
1.13. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 13 physical activity level; Intervention: nutritional supplement.
1.14. Analysis
1.14. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 14 total energy expenditure (MJ); Intervention: nutritional supplement.
1.15. Analysis
1.15. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 15 subgroup analysis (supervised vs. unsupervised); change in step count (steps per day); Intervention: pulmonary rehabilitation/exercise training.
1.16. Analysis
1.16. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 16 supgroup analysis (supervised vs. unsupervised); change in time in light‐intensity physical activity (minutes per day); Intervention: pulmonary rehabilitation/exercise training.
1.17. Analysis
1.17. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 17 subgroup analysis (supervised vs. unsupervised); change in total energy expenditure (kcal); Intervention: pulmonary rehabilitation/exercise training.
1.18. Analysis
1.18. Analysis
Comparison 1 Physical activity: intervention vs. no intervention, Outcome 18 subgroup analysis (supervised vs. unsupervised); change in sedentary time (minutes per day); Intervention: pulmonary rehabilitation/exercise training.
2.1. Analysis
2.1. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 1 step count (steps per day); Intervention: self‐management (health mentoring).
2.2. Analysis
2.2. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 2 change in step count (steps per day); Intervention: LAMA/LABA.
2.3. Analysis
2.3. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 3 change in time in moderate‐to‐vigorous intensity physical activity (minutes per day): Intervention: LAMA/LABA.
2.4. Analysis
2.4. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 4 change in active energy expenditure (kcal); Intervention: LAMA/LABA.
2.5. Analysis
2.5. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 5 step count (steps per day); Intervention: nutritional supplement.
2.6. Analysis
2.6. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 6 energy expenditure for ambulation (kcal/step/FFM kg); Intervention: nutritional supplement.
2.7. Analysis
2.7. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 7 change in step count (steps per day); Intervention: neuromuscular electrical stimulation.
2.8. Analysis
2.8. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 8 change in up/down transitions (number); Intervention: neuromuscular electrical stimulation.
2.9. Analysis
2.9. Analysis
Comparison 2 Physical activity: intervention vs. placebo/sham, Outcome 9 change in time upright (hours); Intervention: neuromuscular electrical stimulation.
3.1. Analysis
3.1. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 1 movement intensity (m/s2); Interventions: nordic walking with education vs. education.
3.2. Analysis
3.2. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 2 change in step count (steps per day); Interventions: exercise training (COPE‐active) with self‐management vs. self management.
3.3. Analysis
3.3. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 3 change in time in light‐intensity physical activity (minutes per day); Interventions: upper body resistance training with health education vs. health education.
3.4. Analysis
3.4. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 4 step count (steps per day); Interventions: LAMA/LABA and exercise training with behaviour modification vs. placebo with behaviour modification.
3.5. Analysis
3.5. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 5 time walking (minutes per day); Interventions: LAMA/LABA and exercise training with behaviour modification vs. placebo with behaviour modification.
3.6. Analysis
3.6. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 6 walking intensity (m/s2); Interventions: LAMA/LABA and exercise training with behaviour modification vs. placebo with behaviour modification.
3.7. Analysis
3.7. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 7 step count (steps per day); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
3.8. Analysis
3.8. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 8 time walking (minutes per day); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
3.9. Analysis
3.9. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 9 walking intensity (m/s2); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
3.10. Analysis
3.10. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 10 step count (steps per day); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.
3.11. Analysis
3.11. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 11 time walking (minutes per day); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.
3.12. Analysis
3.12. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 12 walking intensity (m/s2); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.
3.13. Analysis
3.13. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 13 change in step count (steps per day); Interventions: exercise training and physical activity counselling with pedometer vs. pedometer.
3.14. Analysis
3.14. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 14 change in step count (weekday, steps per day); Interventions: physical activity counselling with optional supervised exercise vs. optional supervised exercise.
3.15. Analysis
3.15. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 15 METs; Interventions: physical activity counselling with optional supervised exercise vs. optional supervised exercise.
3.16. Analysis
3.16. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 16 step count (steps per day); Interventions: physical activity counselling with pedometer vs. pedometer.
3.17. Analysis
3.17. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 17 time active (minutes per day); Interventions: physical activity counselling (app) with pedometer vs. pedometer.
3.18. Analysis
3.18. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 18 time inactive (minutes per day); Interventions: physical activity counselling (app) with pedometer vs. pedometer.
3.19. Analysis
3.19. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 19 peak performance (steps per minute); Interventions: physical activity counselling (app) with pedometer vs. pedometer.
3.20. Analysis
3.20. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 20 step count (steps per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
3.21. Analysis
3.21. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 21 time in moderate‐to‐vigorous intensity physical activity (minutes per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
3.22. Analysis
3.22. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 22 time in physical activity (total, minutes per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
3.23. Analysis
3.23. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 23 time sedentary (minutes per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
3.24. Analysis
3.24. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 24 change in step count (steps per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.25. Analysis
3.25. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 25 change in time in moderate‐to‐vigorous intensity physical activity (minutes per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.26. Analysis
3.26. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 26 change in time walking (minutes per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.27. Analysis
3.27. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 27 change in time in physical activity (total, minutes per day); Interventions: physical activity counselling with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.28. Analysis
3.28. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 28 change in time in light‐intensity physical activity (minutes per day); Interventions: exercise‐specific self‐efficacy training with upper body resistance training vs. upper body resistance training.
3.29. Analysis
3.29. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 29 step count (steps per day); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.
3.30. Analysis
3.30. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 30 time walking (minutes per day); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.
3.31. Analysis
3.31. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 31 walking intensity (m/s2); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.
3.32. Analysis
3.32. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 32 step count (steps per day); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
3.33. Analysis
3.33. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 33 time walking (minutes per day); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
3.34. Analysis
3.34. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 34 walking intensity (m/s2); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
3.35. Analysis
3.35. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 35 step count (steps per day); Interventions: LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
3.36. Analysis
3.36. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 36 time walking (minutes per day); Interventions: LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
3.37. Analysis
3.37. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 37 walking intensity (m/s2); Interventions: LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
3.38. Analysis
3.38. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 38 change in step count (steps per day); Interventions: nutritional supplement with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.
3.39. Analysis
3.39. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 39 change in step count (steps per day); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.40. Analysis
3.40. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 40 change in time in moderate‐intensity physical activity (minutes per day); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.41. Analysis
3.41. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 41 change in time in vigorous‐intensity physical activity (minutes per day); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.42. Analysis
3.42. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 42 change in time in light‐intensity physical activity (minutes per day); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.43. Analysis
3.43. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 43 change in total energy expenditure (kcal); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
3.44. Analysis
3.44. Analysis
Comparison 3 Physical activity: intervention with common intervention vs. common intervention, Outcome 44 change in sedentary time (minutes per day); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
4.1. Analysis
4.1. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 1 change in step count (steps per day); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.2. Analysis
4.2. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 2 change in time in moderate‐to‐vigorous intensity physical activity (minutes per day); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.3. Analysis
4.3. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 3 change in number of bouts of moderate‐to‐vigorous intensity physical activity; Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.4. Analysis
4.4. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 4 change in time in bouts of moderate‐to‐vigorous intensity physical activity(minutes per day); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.5. Analysis
4.5. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 5 change in sedentary time (minutes per day); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.6. Analysis
4.6. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 6 change in sedentary time (awake; minutes per day); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.7. Analysis
4.7. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 7 change in number of sedentary bouts; Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.8. Analysis
4.8. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 8 change in time in sedentary bouts (minutes per day); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.9. Analysis
4.9. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 9 change in METs; Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.10. Analysis
4.10. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 10 change in total energy expenditure (kcal); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
4.11. Analysis
4.11. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 11 change in step count (steps per day); Interventions: water‐based exercise training vs. land‐based exercise training.
4.12. Analysis
4.12. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 12 change in total energy expenditure (kcal); Interventions: water‐based exercise training vs. land‐based exercise training.
4.13. Analysis
4.13. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 13 step count (steps per day); Interventions: Tai Chi vs. pulmonary rehabilitation.
4.14. Analysis
4.14. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 14 step count (steps per day); Interventions: outdoor walking vs. cycle ergometry.
4.15. Analysis
4.15. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 15 step count (steps per day); Interventions: physical activity counselling vs. pulmonary rehabilitation.
4.16. Analysis
4.16. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 16 total energy expenditure (kcal); Interventions: exercise training with tapered supervision vs. supervised exercise training.
4.17. Analysis
4.17. Analysis
Comparison 4 Physical activity: intervention vs. intervention, Outcome 17 mid day activity (vector magnitude units per minute); Interventions: supplemental oxygen (lightweight ambulatory) vs. supplemental oxygen (E‐cylinder).
5.1. Analysis
5.1. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 1 change in SGRQ total score; Intervention: pulmonary rehabilitation/exercise training.
5.2. Analysis
5.2. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 2 change in SGRQ domain scores. Intervention: pulmonary rehabilitation/exercise training (ground‐based walking).
5.3. Analysis
5.3. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 3 change in CRQ domain scores; Intervention: pulmonary rehabilitation/exercise training.
5.4. Analysis
5.4. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 4 CAT score; Intervention: high‐intensity interval training.
5.5. Analysis
5.5. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 5 SGRQ domain scores (%change); Intervention: exercise training [inpatient].
5.6. Analysis
5.6. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 6 SGRQ domain scores; Intervention: physical activity counselling.
5.7. Analysis
5.7. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 7 CCQ domain scores: Intervention: physical activity counselling.
5.8. Analysis
5.8. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 8 change in CCQ domain scores; Intervention: physical activity counselling (telecoaching).
5.9. Analysis
5.9. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 9 change in CRQ domain and total scores; Intervention: physical activity counselling.
5.10. Analysis
5.10. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 10 change in SGRQ domain and total scores; Intervention: physical activity counselling.
5.11. Analysis
5.11. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 11 change in CRQ domain scores; Intervention: self‐management (SPACE).
5.12. Analysis
5.12. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 12 CCQ total score; Intervention: self‐management.
5.13. Analysis
5.13. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 13 EQ5D index score; Intervention: self‐management.
5.14. Analysis
5.14. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 14 EQ5D visual analogue scale score; Intervention: self‐management.
5.15. Analysis
5.15. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 15 SGRQ domain scores; Intervention: self‐management (telephone health coaching).
5.16. Analysis
5.16. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 16 EQ5D score; Intervention: self‐management (telephone health coaching).
5.17. Analysis
5.17. Analysis
Comparison 5 Health‐related quality of life: intervention vs. no intervention, Outcome 17 CRQ domain scores; Intervention: four‐wheeled walker.
6.1. Analysis
6.1. Analysis
Comparison 6 Health‐related quality of life: intervention vs. placebo/sham, Outcome 1 change in SF36 component scores; Intervention: singing.
6.2. Analysis
6.2. Analysis
Comparison 6 Health‐related quality of life: intervention vs. placebo/sham, Outcome 2 change in CRQ total score; Intervention: neuromuscular electrical stimulation.
6.3. Analysis
6.3. Analysis
Comparison 6 Health‐related quality of life: intervention vs. placebo/sham, Outcome 3 change in SGRQ total score; Intervention: neuromuscular electrical stimulation.
6.4. Analysis
6.4. Analysis
Comparison 6 Health‐related quality of life: intervention vs. placebo/sham, Outcome 4 change in EQ5D index score; Intervention: neuromuscular electrical stimulation.
6.5. Analysis
6.5. Analysis
Comparison 6 Health‐related quality of life: intervention vs. placebo/sham, Outcome 5 change in EQ5D visual analogue scale score; Intervention: neuromuscular electrical stimulation.
7.1. Analysis
7.1. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 1 SF36 component scores (score

7.2. Analysis

Comparison 7 Health‐related quality of…

7.2. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.2. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 2 change in CRQ domain scores; Interventions: exercise training (COPE‐active) with self‐management vs. self management.

7.3. Analysis

Comparison 7 Health‐related quality of…

7.3. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.3. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 3 change in CCQ domain scores; Interventions: exercise training (COPE‐active) with self‐management vs. self management.

7.4. Analysis

Comparison 7 Health‐related quality of…

7.4. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.4. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 4 CRQ domain scores; Interventions: LAMA/LABA and exercise training with behaviour modification vs. placebo with behaviour modification.

7.5. Analysis

Comparison 7 Health‐related quality of…

7.5. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.5. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 5 CRQ domain scores; Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.

7.6. Analysis

Comparison 7 Health‐related quality of…

7.6. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.6. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 6 CRQ domain scores; Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.

7.7. Analysis

Comparison 7 Health‐related quality of…

7.7. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.7. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 7 change in SGRQ domain and total scores; Intervention: exercise training and physical activity counselling with pedometer vs. pedometer.

7.8. Analysis

Comparison 7 Health‐related quality of…

7.8. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.8. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 8 change in CRQ domain scores; Interventions: physical activity counselling (app) with optional supervised exercise vs. optional supervised exercise.

7.9. Analysis

Comparison 7 Health‐related quality of…

7.9. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.9. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 9 change in SGRQ total score; Interventions: physical activity counselling with pedometer vs. pedometer.

7.10. Analysis

Comparison 7 Health‐related quality of…

7.10. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.10. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 10 SGRQ total: Interventions: physical activity counselling (app) with pedometer vs. pedometer.

7.11. Analysis

Comparison 7 Health‐related quality of…

7.11. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.11. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 11 SF36: Interventions: physical activity counselling (app) with pedometer vs. pedometer.

7.12. Analysis

Comparison 7 Health‐related quality of…

7.12. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.12. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 12 change in SGRQ domain scores; Interventions: physical activity counselling (web‐based) with pedometer vs. pedometer.

7.13. Analysis

Comparison 7 Health‐related quality of…

7.13. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.13. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 13 SGRQ domain scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.

7.14. Analysis

Comparison 7 Health‐related quality of…

7.14. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.14. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 14 RAND36 domain scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.

7.15. Analysis

Comparison 7 Health‐related quality of…

7.15. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.15. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 15 change in CRQ dyspnoea domain score; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.

7.16. Analysis

Comparison 7 Health‐related quality of…

7.16. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.16. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 16 SGRQ scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.

7.17. Analysis

Comparison 7 Health‐related quality of…

7.17. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.17. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 17 CRQ domain scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.

7.18. Analysis

Comparison 7 Health‐related quality of…

7.18. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.18. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 18 change in CRQ total score; Interventions: physical activity counselling with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.

7.19. Analysis

Comparison 7 Health‐related quality of…

7.19. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.19. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 19 change in CRQ scores; Interventions: self‐management (health coaching) with pulmonary rehabilitation referral vs. pulmonary rehabilitation referral.

7.20. Analysis

Comparison 7 Health‐related quality of…

7.20. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.20. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 20 CRQ domain scores; Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.

7.21. Analysis

Comparison 7 Health‐related quality of…

7.21. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.21. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 21 CRQ domain scores; Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.

7.22. Analysis

Comparison 7 Health‐related quality of…

7.22. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.22. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 22 CRQ domain scores; Interventions: LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.

7.23. Analysis

Comparison 7 Health‐related quality of…

7.23. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.23. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 23 change in SGRQ domain and total scores; Interventions: ACE inhibitor with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.

7.24. Analysis

Comparison 7 Health‐related quality of…

7.24. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.24. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 24 change in SGRQ total score; Interventions: nutritional supplement with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.

7.25. Analysis

Comparison 7 Health‐related quality of…

7.25. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.25. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 25 change in EQ5D; Interventions: nutritional supplement with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.

7.26. Analysis

Comparison 7 Health‐related quality of…

7.26. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.26. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 26 change in CRQ domain scores; Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.

7.27. Analysis

Comparison 7 Health‐related quality of…

7.27. Analysis

Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention,…

7.27. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 27 CRQ domain scores; Interventions: non‐invasive ventilation with pulmonary rehabilitation vs. pulmonary rehabilitation.

8.1. Analysis

Comparison 8 Exercise capacity: intervention…

8.1. Analysis

Comparison 8 Exercise capacity: intervention vs. placebo/sham, Outcome 1 change in 6MWD (metres);…

8.1. Analysis
Comparison 8 Exercise capacity: intervention vs. placebo/sham, Outcome 1 change in 6MWD (metres); Intervention; neuromuscular electrical stimulation.

9.1. Analysis

Comparison 9 Exercise capacity: intervention…

9.1. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 1 change in 6MWD…

9.1. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 1 change in 6MWD (metres); Intervention: pulmonary rehabilitation/exercise training.

9.2. Analysis

Comparison 9 Exercise capacity: intervention…

9.2. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 2 change in ISWD…

9.2. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 2 change in ISWD (metres); Intervention: pulmonary rehabilitation/exercise training.

9.3. Analysis

Comparison 9 Exercise capacity: intervention…

9.3. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 3 change in ESWT…

9.3. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 3 change in ESWT (seconds); Intervention: pulmonary rehabilitation/exercise training.

9.4. Analysis

Comparison 9 Exercise capacity: intervention…

9.4. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 4 6MWD (metres); Intervention:…

9.4. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 4 6MWD (metres); Intervention: high‐intensity interval training.

9.5. Analysis

Comparison 9 Exercise capacity: intervention…

9.5. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 5 work rate (watts);…

9.5. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 5 work rate (watts); Intervention: high‐intensity interval training.

9.6. Analysis

Comparison 9 Exercise capacity: intervention…

9.6. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 6 change in ISWD…

9.6. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 6 change in ISWD (metres); Intervention: self‐management (SPACE).

9.7. Analysis

Comparison 9 Exercise capacity: intervention…

9.7. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 7 change in ESWT…

9.7. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 7 change in ESWT (seconds); Intervention: self‐management (SPACE).

9.8. Analysis

Comparison 9 Exercise capacity: intervention…

9.8. Analysis

Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 8 6MWD (metres); Intervention:…

9.8. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 8 6MWD (metres); Intervention: exercise training [inpatient].

10.1. Analysis

Comparison 10 Health‐related quality of…

10.1. Analysis

Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 1 change in…

10.1. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 1 change in CRQ domains; Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.

10.2. Analysis

Comparison 10 Health‐related quality of…

10.2. Analysis

Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 2 change in…

10.2. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 2 change in CRQ domains; Interventions: water‐based exercise training vs. land‐based exercise training.

10.3. Analysis

Comparison 10 Health‐related quality of…

10.3. Analysis

Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 3 SGRQ domain…

10.3. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 3 SGRQ domain and total scores; Interventions: Tai Chi vs. pulmonary rehabilitation.

10.4. Analysis

Comparison 10 Health‐related quality of…

10.4. Analysis

Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 4 CRQ total…

10.4. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 4 CRQ total score; Interventions: outdoor walking vs. cycle ergometry.

10.5. Analysis

Comparison 10 Health‐related quality of…

10.5. Analysis

Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 5 Maugeri Respiratory…

10.5. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 5 Maugeri Respiratory Failure questionnaire; Interventions: exercise training with tapered supervision vs. supervised exercise training.

10.6. Analysis

Comparison 10 Health‐related quality of…

10.6. Analysis

Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 6 SF36 domain…

10.6. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 6 SF36 domain scores; Interventions: self‐management vs. education and symptom monitoring.

11.1. Analysis

Comparison 11 Exercise capacity: intervention…

11.1. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 1…

11.1. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 1 6MWD (metres); Interventions: Nordic walking with education vs. education.

11.2. Analysis

Comparison 11 Exercise capacity: intervention…

11.2. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 2…

11.2. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 2 change in ISWD (metres); Interventions: exercise training (COPE‐active) with self‐management vs. self management.

11.3. Analysis

Comparison 11 Exercise capacity: intervention…

11.3. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 3…

11.3. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 3 change in ESWT (seconds); Interventions: exercise training (COPE‐active) with self‐management vs. self management.

11.4. Analysis

Comparison 11 Exercise capacity: intervention…

11.4. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 4…

11.4. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 4 6MWD (metres); Interventions: exercise training and LAMA/LABA with behaviour modification vs. placebo with behaviour modification.

11.5. Analysis

Comparison 11 Exercise capacity: intervention…

11.5. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 5…

11.5. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 5 ESWT (seconds); Interventions: exercise training and LAMA/LABA with behaviour modification vs. placebo with behaviour modification.

11.6. Analysis

Comparison 11 Exercise capacity: intervention…

11.6. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 6…

11.6. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 6 6MWD (metres); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.

11.7. Analysis

Comparison 11 Exercise capacity: intervention…

11.7. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 7…

11.7. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 7 ESWT (seconds); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.

11.8. Analysis

Comparison 11 Exercise capacity: intervention…

11.8. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 8…

11.8. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 8 6MWD (metres); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.

11.9. Analysis

Comparison 11 Exercise capacity: intervention…

11.9. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 9…

11.9. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 9 ESWT (seconds); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.

11.10. Analysis

Comparison 11 Exercise capacity: intervention…

11.10. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 10…

11.10. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 10 change in ESWT (seconds); Intervention: physical activity counselling and exercise training with pedometer vs. pedometer.

11.11. Analysis

Comparison 11 Exercise capacity: intervention…

11.11. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 11…

11.11. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 11 6MWD (metres); Interventions: physical activity counselling (app) with optional supervised exercise vs. optional supervised exercise.

11.12. Analysis

Comparison 11 Exercise capacity: intervention…

11.12. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 12…

11.12. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 12 6MWD (metres); Interventions: physical activity counselling (app) with pedometer vs. pedometer.

11.13. Analysis

Comparison 11 Exercise capacity: intervention…

11.13. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 13…

11.13. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 13 6MWD (metres); Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.

11.14. Analysis

Comparison 11 Exercise capacity: intervention…

11.14. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 14…

11.14. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 14 change in 6MWD (metres); Interventions: physical activity counselling with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.

11.15. Analysis

Comparison 11 Exercise capacity: intervention…

11.15. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 15…

11.15. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 15 6MWD (metres); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.

11.16. Analysis

Comparison 11 Exercise capacity: intervention…

11.16. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 16…

11.16. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 16 ESWT (seconds); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.

11.17. Analysis

Comparison 11 Exercise capacity: intervention…

11.17. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 17…

11.17. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 17 6MWD (metres); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.

11.18. Analysis

Comparison 11 Exercise capacity: intervention…

11.18. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 18…

11.18. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 18 ESWT (s); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.

11.19. Analysis

Comparison 11 Exercise capacity: intervention…

11.19. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 19…

11.19. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 19 6MWD (metres); Interventions: LAMA/LABA with behaviour modification vs. LAMA with behaviour modification.

11.20. Analysis

Comparison 11 Exercise capacity: intervention…

11.20. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 20…

11.20. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 20 ESWT (seconds); Interventions: LAMA/LABA with behaviour modification vs. LAMA with behaviour modification.

11.21. Analysis

Comparison 11 Exercise capacity: intervention…

11.21. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 21…

11.21. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 21 change in ISWD (metres); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.

11.22. Analysis

Comparison 11 Exercise capacity: intervention…

11.22. Analysis

Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 22…

11.22. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 22 change in ESWT (seconds); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.

12.1. Analysis

Comparison 12 Exercise capacity: intervention…

12.1. Analysis

Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 1 change in 6MWD (metres);…

12.1. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 1 change in 6MWD (metres); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.

12.2. Analysis

Comparison 12 Exercise capacity: intervention…

12.2. Analysis

Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 2 change in 6MWD (metres);…

12.2. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 2 change in 6MWD (metres); Interventions: water‐based exercise training vs. land‐based exercise training.

12.3. Analysis

Comparison 12 Exercise capacity: intervention…

12.3. Analysis

Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 3 change in ISWD (metres);…

12.3. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 3 change in ISWD (metres); Interventions: water‐based exercise training vs. land‐based exercise training.

12.4. Analysis

Comparison 12 Exercise capacity: intervention…

12.4. Analysis

Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 4 change in VO 2…

12.4. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 4 change in VO2max (ml/min); Interventions: water‐based exercise training vs. land‐based exercise training.

12.5. Analysis

Comparison 12 Exercise capacity: intervention…

12.5. Analysis

Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 5 6MWD (metres); Interventions: Tai…

12.5. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 5 6MWD (metres); Interventions: Tai Chi vs. pulmonary rehabilitation.

12.6. Analysis

Comparison 12 Exercise capacity: intervention…

12.6. Analysis

Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 6 6MWD (metres); Interventions: exercise…

12.6. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 6 6MWD (metres); Interventions: exercise training with tapered supervision vs. supervised exercise training.
All figures (195)
7.2. Analysis
7.2. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 2 change in CRQ domain scores; Interventions: exercise training (COPE‐active) with self‐management vs. self management.
7.3. Analysis
7.3. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 3 change in CCQ domain scores; Interventions: exercise training (COPE‐active) with self‐management vs. self management.
7.4. Analysis
7.4. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 4 CRQ domain scores; Interventions: LAMA/LABA and exercise training with behaviour modification vs. placebo with behaviour modification.
7.5. Analysis
7.5. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 5 CRQ domain scores; Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
7.6. Analysis
7.6. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 6 CRQ domain scores; Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.
7.7. Analysis
7.7. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 7 change in SGRQ domain and total scores; Intervention: exercise training and physical activity counselling with pedometer vs. pedometer.
7.8. Analysis
7.8. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 8 change in CRQ domain scores; Interventions: physical activity counselling (app) with optional supervised exercise vs. optional supervised exercise.
7.9. Analysis
7.9. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 9 change in SGRQ total score; Interventions: physical activity counselling with pedometer vs. pedometer.
7.10. Analysis
7.10. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 10 SGRQ total: Interventions: physical activity counselling (app) with pedometer vs. pedometer.
7.11. Analysis
7.11. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 11 SF36: Interventions: physical activity counselling (app) with pedometer vs. pedometer.
7.12. Analysis
7.12. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 12 change in SGRQ domain scores; Interventions: physical activity counselling (web‐based) with pedometer vs. pedometer.
7.13. Analysis
7.13. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 13 SGRQ domain scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
7.14. Analysis
7.14. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 14 RAND36 domain scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
7.15. Analysis
7.15. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 15 change in CRQ dyspnoea domain score; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
7.16. Analysis
7.16. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 16 SGRQ scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
7.17. Analysis
7.17. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 17 CRQ domain scores; Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
7.18. Analysis
7.18. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 18 change in CRQ total score; Interventions: physical activity counselling with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.
7.19. Analysis
7.19. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 19 change in CRQ scores; Interventions: self‐management (health coaching) with pulmonary rehabilitation referral vs. pulmonary rehabilitation referral.
7.20. Analysis
7.20. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 20 CRQ domain scores; Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.
7.21. Analysis
7.21. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 21 CRQ domain scores; Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
7.22. Analysis
7.22. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 22 CRQ domain scores; Interventions: LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
7.23. Analysis
7.23. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 23 change in SGRQ domain and total scores; Interventions: ACE inhibitor with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.
7.24. Analysis
7.24. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 24 change in SGRQ total score; Interventions: nutritional supplement with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.
7.25. Analysis
7.25. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 25 change in EQ5D; Interventions: nutritional supplement with pulmonary rehabilitation vs. placebo with pulmonary rehabilitation.
7.26. Analysis
7.26. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 26 change in CRQ domain scores; Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.
7.27. Analysis
7.27. Analysis
Comparison 7 Health‐related quality of life: intervention with common intervention vs. common intervention, Outcome 27 CRQ domain scores; Interventions: non‐invasive ventilation with pulmonary rehabilitation vs. pulmonary rehabilitation.
8.1. Analysis
8.1. Analysis
Comparison 8 Exercise capacity: intervention vs. placebo/sham, Outcome 1 change in 6MWD (metres); Intervention; neuromuscular electrical stimulation.
9.1. Analysis
9.1. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 1 change in 6MWD (metres); Intervention: pulmonary rehabilitation/exercise training.
9.2. Analysis
9.2. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 2 change in ISWD (metres); Intervention: pulmonary rehabilitation/exercise training.
9.3. Analysis
9.3. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 3 change in ESWT (seconds); Intervention: pulmonary rehabilitation/exercise training.
9.4. Analysis
9.4. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 4 6MWD (metres); Intervention: high‐intensity interval training.
9.5. Analysis
9.5. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 5 work rate (watts); Intervention: high‐intensity interval training.
9.6. Analysis
9.6. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 6 change in ISWD (metres); Intervention: self‐management (SPACE).
9.7. Analysis
9.7. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 7 change in ESWT (seconds); Intervention: self‐management (SPACE).
9.8. Analysis
9.8. Analysis
Comparison 9 Exercise capacity: intervention vs. no intervention, Outcome 8 6MWD (metres); Intervention: exercise training [inpatient].
10.1. Analysis
10.1. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 1 change in CRQ domains; Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
10.2. Analysis
10.2. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 2 change in CRQ domains; Interventions: water‐based exercise training vs. land‐based exercise training.
10.3. Analysis
10.3. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 3 SGRQ domain and total scores; Interventions: Tai Chi vs. pulmonary rehabilitation.
10.4. Analysis
10.4. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 4 CRQ total score; Interventions: outdoor walking vs. cycle ergometry.
10.5. Analysis
10.5. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 5 Maugeri Respiratory Failure questionnaire; Interventions: exercise training with tapered supervision vs. supervised exercise training.
10.6. Analysis
10.6. Analysis
Comparison 10 Health‐related quality of life: intervention vs. intervention, Outcome 6 SF36 domain scores; Interventions: self‐management vs. education and symptom monitoring.
11.1. Analysis
11.1. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 1 6MWD (metres); Interventions: Nordic walking with education vs. education.
11.2. Analysis
11.2. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 2 change in ISWD (metres); Interventions: exercise training (COPE‐active) with self‐management vs. self management.
11.3. Analysis
11.3. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 3 change in ESWT (seconds); Interventions: exercise training (COPE‐active) with self‐management vs. self management.
11.4. Analysis
11.4. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 4 6MWD (metres); Interventions: exercise training and LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
11.5. Analysis
11.5. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 5 ESWT (seconds); Interventions: exercise training and LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
11.6. Analysis
11.6. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 6 6MWD (metres); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
11.7. Analysis
11.7. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 7 ESWT (seconds); Interventions: exercise training and LABA with LAMA and behaviour modification vs. LAMA and behaviour modification.
11.8. Analysis
11.8. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 8 6MWD (metres); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.
11.9. Analysis
11.9. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 9 ESWT (seconds); Interventions: exercise training with LAMA/LABA and behaviour modification vs. LAMA/LABA and behaviour modification.
11.10. Analysis
11.10. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 10 change in ESWT (seconds); Intervention: physical activity counselling and exercise training with pedometer vs. pedometer.
11.11. Analysis
11.11. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 11 6MWD (metres); Interventions: physical activity counselling (app) with optional supervised exercise vs. optional supervised exercise.
11.12. Analysis
11.12. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 12 6MWD (metres); Interventions: physical activity counselling (app) with pedometer vs. pedometer.
11.13. Analysis
11.13. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 13 6MWD (metres); Interventions: physical activity counselling with pulmonary rehabilitation vs. pulmonary rehabilitation.
11.14. Analysis
11.14. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 14 change in 6MWD (metres); Interventions: physical activity counselling with pulmonary rehabilitation vs. sham with pulmonary rehabilitation.
11.15. Analysis
11.15. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 15 6MWD (metres); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.
11.16. Analysis
11.16. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 16 ESWT (seconds); Interventions: LAMA with behaviour modification vs. placebo with behaviour modification.
11.17. Analysis
11.17. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 17 6MWD (metres); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
11.18. Analysis
11.18. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 18 ESWT (s); Interventions: LAMA/LABA with behaviour modification vs. placebo with behaviour modification.
11.19. Analysis
11.19. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 19 6MWD (metres); Interventions: LAMA/LABA with behaviour modification vs. LAMA with behaviour modification.
11.20. Analysis
11.20. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 20 ESWT (seconds); Interventions: LAMA/LABA with behaviour modification vs. LAMA with behaviour modification.
11.21. Analysis
11.21. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 21 change in ISWD (metres); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.
11.22. Analysis
11.22. Analysis
Comparison 11 Exercise capacity: intervention with common intervention vs. common intervention, Outcome 22 change in ESWT (seconds); Interventions: supplemental oxygen with pulmonary rehabilitation vs. sham intervention with pulmonary rehabilitation.
12.1. Analysis
12.1. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 1 change in 6MWD (metres); Interventions: home‐based pulmonary rehabilitation vs. centre‐based pulmonary rehabilitation.
12.2. Analysis
12.2. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 2 change in 6MWD (metres); Interventions: water‐based exercise training vs. land‐based exercise training.
12.3. Analysis
12.3. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 3 change in ISWD (metres); Interventions: water‐based exercise training vs. land‐based exercise training.
12.4. Analysis
12.4. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 4 change in VO2max (ml/min); Interventions: water‐based exercise training vs. land‐based exercise training.
12.5. Analysis
12.5. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 5 6MWD (metres); Interventions: Tai Chi vs. pulmonary rehabilitation.
12.6. Analysis
12.6. Analysis
Comparison 12 Exercise capacity: intervention vs. intervention, Outcome 6 6MWD (metres); Interventions: exercise training with tapered supervision vs. supervised exercise training.

References

References to studies included in this review Alison 2019 {published data only}

    1. Alison JA, McKeough ZJ, Jenkins SC, Holland AE, Hill K, Morris NR, et al. A randomised controlled trial of supplemental oxygen versus medical air during exercise training in people with chronic obstructive pulmonary disease: supplemental oxygen in pulmonary rehabilitation trial (SuppORT) [protocol]. BMC Pulmonary Medicine 2016;1:25.
    1. Alison JA, McKeough ZJ, Leung RW, Holland AE, Hill K, Morris NR, et al. Oxygen compared to air during exercise training in COPD with exercise‐induced desaturation. European Respiratory Journal 2019;53:1802429.
Altenburg 2015 {published data only}
    1. Altenburg W, Wempe J, Greef M, Hacken N, Kerstjens H. Short‐ and long‐term effects of a physical activity counselling program in COPD [abstract]. European Respiratory Journal 2014;44:3490.
    1. Altenburg WA, Hacken NH, Bossenbroek L, Kerstjens HA, Greef MH, Wempe JB. Short‐ and long‐term effects of a physical activity counselling programme in COPD: a randomized controlled trial. Respiratory Medicine 2015;109(1):112‐21.
Arbillaga‐Etxarri 2018 {published data only}
    1. Arbillaga‐Etxarri A, Gimeno‐Santos E, Balcells E, Barberan‐Garcia A, Benet M, Celorrio N, et al. Effectiveness of an intervention of urban training in patients with COPD: a randomized controlled trial [abstract]. European Respiratory Journal 2017;50:OA513.
    1. Arbillaga‐Etxarri A, Gimeno‐Santos E, Barberan‐Garcia A, Balcells E, Benet M, Borrell E, et al. Long‐term efficacy and effectiveness of a behavioural and community‐based exercise intervention (Urban Training™) to increase physical activity in patients with COPD. A randomised controlled trial. European Respiratory Journal 2018;52(4):1800063.
    1. Arbillaga‐Etxarri A, Torrent‐Pallicer J, Gimeno‐Santos E, Barberan‐Garcia A, Delgado A, Balcells E, et al. Validation of walking trails for the urban training of chronic obstructive disease patients. PLoS ONE 2016;11(1):e0146705.
Beeh 2014 {published and unpublished data}
    1. Beeh KM, Watz H, Puente‐Maestu L, Teresa L, Jarreta D, Caracta C, et al. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo‐controlled, crossover trial. BMC Pulmonary Medicine 2014;14(1):209.
Bender 2016 {published data only}
    1. Bender BG, Depew A, Emmett A, Goelz K, Make B, Sharma S, et al. A patient‐centered walking program for COPD. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2016;3(4):769‐77.
    1. Bender BG, Make BJ, Emmett A, Sharma S, Stempel D. Enhancing physical activity in patients with chronic obstructive pulmonary disease (COPD) through a program of patient selected goals [abstract]. American Journal of Respiratory and Critical Care Medicine 2015;191:A2458.
Benzo 2016 {published data only (unpublished sought but not used)}
    1. Benzo R, McEvoy C. Effect of health coaching delivered by a respiratory therapist or nurse on self‐management abilities in severe COPD: analysis of a large randomized study. Respiratory Care 2019;64(9):1065‐72.
    1. Benzo R, Vickers K, Ernst D, Tucker S, McEvoy C, Lorig K. Development and feasibility of a self‐management intervention for chronic obstructive pulmonary disease delivered with motivational interviewing strategies. Journal of Cardiopulmonary Rehabilitation and Prevention 2013;33(2):113‐22.
    1. Benzo R, Vickers K, Novotny PJ, Tucker S, Hoult J, Neuenfeldt P, et al. Health coaching and chronic obstructive pulmonary disease rehospitalization: a randomized study. American Journal of Respiratory and Critical Care Medicine 2016;194(6):672‐80.
Blumenthal 2014 {published data only}
    1. Blumenthal JA, Emery CF, Smith PJ, Keefe FJ, Welty‐Wolf K, Mabe S, et al. The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE‐II study. Psychosomatic Medicine 2014;76(8):581‐92.
    1. Blumenthal JA, Keefe FJ, Babyak MA, Fenwick CV, Johnson JM, Stott K, et al. Caregiver‐assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIREII study. Clinical Trials 2009;6(2):172‐84.
Borges 2014 {published and unpublished data}
    1. Borges R, Carvalho CR. Effect of resistance training during hospitalization in the systemic inflammation, functional capacity and muscle strength in COPD patients [abstract]. European Respiratory Journal 2011;38:1890.
    1. Borges RC, Carvalho CR. Impact of resistance training in chronic obstructive pulmonary disease patients during periods of acute exacerbation. Archives of Physical Medicine and Rehabilitation 2014;95(9):1638‐45.
Breyer 2010 {published data only (unpublished sought but not used)}
    1. Breyer MK, Breyer‐Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, et al. Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respiratory Research 2010;11:112.
    1. Breyer MK, Kohansal R, Burghuber OC, Hartl S. The effects of Nordic walking on exercise capacity and physical activity in daily life (AoDL) in COPD [abstract]. European Respiratory Journal 2008;32(Supp 52):1754.
Burtin 2015 {published data only}
    1. Burtin C, Lander D, Remoortel H, Gosselinki R, Decramer M, Janssens W, et al. Physical activity counseling and long‐term effects of pulmonary rehabilitation [abstract]. American Journal of Respiratory and Critical Care Medicine 2012;185:A3675.
    1. Burtin C, Langer D, Remoortel H, Demeyer H, Gosselink R, Decramer M, et al. Physical activity counselling during pulmonary rehabilitation in patients with COPD: a randomised controlled trial. PLOS One 2015;10(12):e0144989.
    1. Burtin C, Langer D, Remoortel J, Demeyer H, Gosselink R, Decramer M, et al. Correction: Physical activity counselling during pulmonary rehabilitation in patients with COPD: a randomised controlled trial. PLOS One 2016;11(2):e0148705.
Casaburi 2012 {published data only}
    1. Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, et al: for the COPD Clinical Research Network. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long‐term oxygen therapy. Journal of Chronic Obstructive Pulmonary Disease 2012;9(1):3‐11.
Chaplin 2017 {published data only}
    1. Barnes A, Newby C, Chaplin E, Houchen‐Wolloff, Singh SJ. Purposeful physical activity in COPD patients comparing standard and web based pulmonary rehabilitation [abstract]. European Respiratory Journal 2016;48(Supp 60):PA2056.
    1. Chaplin E, Hewitt S, Apps L, Bankart J, Pulikottil‐Jacob R, Boyce S, et al. Interactive web‐based pulmonary rehabilitation programme: a randomised controlled feasibility trial. BMJ Open 2017;7(3):e013682.
    1. Chaplin E, Hewitt S, Apps L, Edwards K, Brough C, Glab A, et al. An interactive web‐based programme: a randomised controlled feasibility trial [abstract]. European Respiratory Journal 2016;48(Suppl 60):PA2064.
    1. Chaplin E, Hewitt S, Apps L, Edwards K, Brough C, Glab A, et al. The evaluation of an interactive web‐based pulmonary rehabilitation programme: protocol for the WEB SPACE for COPD feasibility study. BMJ Open 2015;5(8):e008055.
Charususin 2018 {published data only}
    1. Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, et al. Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD. Thorax 2018;73(10):942‐50.
    1. Charususin N, Gosselink R, Decramer M, McConnell A, Saey D, Maltais F, et al. Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): A multicentre randomised controlled trial. BMJ Open 2013;3(8):e003101.
Cruz 2016 {published data only}
    1. Cruz J, Brooks D, Marques A. Walk2Bactive: a randomised controlled trial of a physical activity‐focused behavioural intervention beyond pulmonary rehabilitation in chronic obstructive pulmonary disease. Chronic Respiratory Disease 2016;13(1):57‐66.
Curtis 2016 {published data only}
    1. Curtis KJ, Meyrick VM, Mehta B, Haji GS, Li K, Montgomery H, et al. Angiotensin‐converting enzyme inhibition as an adjunct to pulmonary rehabilitation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2016;194(11):1349‐57.
Dal Negro 2012 {published data only (unpublished sought but not used)}
    1. Dal Negro RW, Aquilani R, Bertacco S, Boschi F, Micheletto C, Tognella S. Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. Monaldi Archives of Chest Disease 2010;73(1):25‐33.
    1. Dal Negro RW, Testa A, Aquilani R, Tognella S, Pasini E, Barbieri A, et al. Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation. Monaldi Archives of Chest Disease 2012;77(2):67‐75.
De Blok 2006 {published data only}
    1. Blok BM, Greef MH, Hacken NH, Sprenger SR, Postema K, Wempe JB. The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD a pilot study [abstract]. European Respiratory Journal 2005;26(Suppl 49):548.
    1. Blok BM, Greef MH, Hacken NH, Sprenger SR, Postema K, Wempe JB. The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Education and Counseling 2006;61(1):48‐55.
Demeyer 2017 {published and unpublished data}
    1. Demeyer H, Louvaris Z, Frei A, Rabinovich RA, Jong C, Gimeno‐Santos E, et al: on behalf of the Mr Papp PROactive study group and the PROactive consortium. Physical activity is increased by a 12‐week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial. Thorax 2017;72(5):415‐23.
    1. Demeyer H, Louvaris Z, Tanner R, Rubio N, Frei A, Jong C, et al. Increasing physical activity in patients with COPD using a telecoaching program: a multicentre RCT [abstract]. European Respiratory Journal 2015;46:OA278.
    1. Loeckx M, Louvaris Z, Tanner R, Rubio N, Frej A, Jong C, et al. Contact time between patients with COPD and coach during an activity telecoaching intervention: Impact on the intervention effect [abstract]. European Respiratory Journal 2016;48(Suppl 60):OA4817.
    1. Loeckx M, Louvaris Z, Tanner RJ, Yerramasu C, Busching G, Frei A, et al. Compliance with a three month telecoaching program to enhance physical activity in patients with Chronic Obstructive Pulmonary Disease [abstract]. American Journal of Respiratory and Critical Care Medicine 2015;191:A2007.
    1. Loeckx M, Rabinovich RA, Demeyer H, Louvaris Z, Tanner R, Rubio N, et al. Smartphone‐based physical activity telecoaching in chronic obstructive pulmonary disease: mixed‐methods study on patient experiences and lessons for implementation. JMIR mHealth and uHealth 2018;6(2):e200.
De Roos 2017 {published and unpublished data}
    1. Roos P, Lucas C, Strijbos JH, Trijffel E. Effectiveness of a combined exercise training and home‐based walking programme on physical activity compared with standard medical care in moderate COPD: a randomised controlled trial. Physiotherapy 2017;104(1):116‐21.
Duiverman 2008 {published data only}
    1. Duiverman ML, Bladder G, Wempe JB, Kerstjens HA, Zijlstra JG, Wijkstra PJ. Chronic ventilatory support improves the outcomes of rehabilitation in hypercapnic COPD patients [abstract]. American Thoracic Society International Conference; 2008 May 16‐21; Toronto. 2008:A557.
    1. Duiverman ML, Wempe JB, Bladder G, Jansen DF, Kerstjens HA, Zijlstra JG, et al. Nocturnal non‐invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax 2008;63(12):1052‐7.
Effing 2011 {published data only}
    1. Effing T, Zielhuis G, Kerstjens H, Valk P, Palen J. Community based physiotherapeutic exercise in COPD self‐management: a randomised controlled trial. Respiratory Medicine 2011;105(3):418‐26.
    1. Zwerink M, Effing T, Kerstjens HA, Valk P, Brusse‐Keizer M, Zielhuis G, et al. Cost‐effectiveness of a community‐based exercise programme in COPD self‐management. Journal of Chronic Obstructive Pulmonary Disease 2016;13(2):214‐23.
    1. Zwerink M, Palen J, Kerstjens HA, Valk P, Brusse‐Keizer M, Zielhuis G, et al. A community‐based exercise programme in COPD self‐management: two years follow‐up of the COPD‐II study. Respiratory Medicine 2014;108(10):1481‐90.
    1. Zwerink M, Palen J, Kerstjens HA, Valk P, Brusse‐Keizer M, Zielhuis G, et al. A community‐based exercise programme in COPD self‐management: two‐year follow‐up of the COPD‐II study [abstract]. European Respiratory Journal 2014;44:1711.
    1. Zwerink M, Palen J, Valk P, Brusse‐Keizer M, Effing T. Relationship between daily physical activity and exercise capacity in patients with COPD. Respiratory Medicine 2013;102(2):242‐8.
Egan 2010 {published and unpublished data}
    1. Egan C, Costello R, Deering B, McCormack NM, Blake C. Physical activity in COPD patients following pulmonary rehabilitation [abstract]. European Respiratory Society 20th Annual Congress; 2010 Sep 18‐22; Barcelona. 2010:E3535.
    1. Egan C, Deering BM, Blake C, Fullen BM, McCormack NM, Spruit MA, et al. Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respiratory Medicine 2012;106(12):1671‐9.
Felcar 2018 {published data only}
    1. Felcar JM, Probst VS, Carvalho DR, Merli MF, Mesquita R, Vidotto LS, et al. Effects of exercise training in water and on land in patients with COPD: a randomised clinical trial. Physiotherapy 2018;104(4):408‐16.
    1. Felcar JM, Probst VS, Carvalho DR, Merli MF, Mesquita RB, Vidotto LS, et al. Effects of exercise training in water and on land in patients with COPD [abstract]. European Respiratory Journal 2015;46(Suppl 59):PA2396.
Gamper 2019 {published data only}
    1. Gamper E, Schmidt U, Bansi J, Kool J. Outdoor walking training compared to cycle ergometer training in severe COPD: a randomized controlled feasibility trial. COPD: Journal of Chronic Obstructive Pulmonary Disease 2019;16(1):37‐44.
Goris 2003 {published data only}
    1. Goris AH, Vermeeren MA, Wouters EF, Schols AM, Westerterp KR. Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation. British Journal of Nutrition 2003;89(5):725‐9.
Hartman 2016 {published data only}
    1. Hartman JE, Klooster K, Slebos DJ, Hacken NH. Daily physical activity significantly improves after endobronchial valve treatment in patients with emphysema [abstract]. European Respiratory Journal 2015;46:OA1767.
    1. Hartman JE, Klooster K, Slebos DJ, Hacken NH. Improvement of physical activity after endobronchial valve treatment in emphysema patients. Respiratory Medicine 2016;117:116‐21.
Holland 2017 {published data only}
    1. Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Cox NS, et al. Home‐based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax 2017;72(1):57‐65.
    1. Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Cox NS, et al. Low cost home‐based pulmonary rehabilitation for chronic obstructive pulmonary disease: a randomized controlled equivalence trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2016;193:A2620.
    1. Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Moore R, et al. Benefits and costs of home‐based pulmonary rehabilitation in chronic obstructive pulmonary disease ‐ a multi‐centre randomised controlled equivalence trial [protocol]. BMC Pulmonary Medicine 2013;13:57.
    1. Lahham A, McDonald CF, Mahal A, Lee AL, Hill CJ, Burge AT, et al. Participation in physical activity during center and home‐based pulmonary rehabilitation for people with COPD: a secondary analysis of a randomized controlled trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2019;39:E1‐4.
    1. Liacos A, McDonald CF, Mahal A, Hill CJ, Lee AL, Burge AT, et al. The Pulmonary Rehabilitation Adapted Index of Self‐Efficacy (PRAISE) tool predicts reduction in sedentary time following pulmonary rehabilitation in people with chronic obstructive pulmonary disease (COPD). Physiotherapy 2019;105(1):90‐7.
Hornikx 2015 {published data only}
    1. Hornikx M, Demeyer H, Camillo CA, Janssens W, Troosters T. The effects of a physical activity counseling program after an exacerbation in patients with chronic obstructive pulmonary disease: a randomized controlled pilot study. BMC Pulmonary Medicine 2015;15:136.
    1. Hornikx M, Demeyer H, Camillo CA, Janssens W, Troosters T. The effects of physical activity coaching in patients with COPD after an acute exacerbation [abstract]. European Respiratory Journal 2014;44:1920.
Hospes 2009 {published data only (unpublished sought but not used)}
    1. Hospes G, Bossenbroek L, Hacken NH, Hengel P, Greef MH. Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. Patient Education and Counseling 2009;75(2):274‐8.
    1. Hospes G, Hacken NH, Hengel P, Greef MH. Pedometer‐based exercise counseling in COPD [abstract]. American Thoracic Society International Conference; 2007 May 18‐23; San Francisco. 2007; Vol. 175:A601.
Jolly 2018 {published data only}
    1. Jolly K, Sidhu MS, Hewitt CA, Coventry PA, Daley A, Jordan R, et al. Self management of patients with mild COPD in primary care: randomised controlled trial. BMJ 2018;361:k2241.
    1. Sidhu MS, Daley A, Jordan R, Coventry PA, Heneghan C, Jowett S, et al. Patient self‐management in primary care patients with mild COPD – protocol of a randomised controlled trial of telephone health coaching. BMC Pulmonary Medicine 2015;15(1):16.
Kanabar 2015 {published and unpublished data}
    1. Kanabar P, Warrington V, Houchen‐Wolloff L, Singh SJ. Investigating the profile of physical activity in COPD patients 7 days post discharge from a respiratory‐related admission. Does brief advice have an effect? [abstract]. Thorax 2015;70(Suppl 3):A146.
Kawagoshi 2015 {published data only}
    1. Kawagoshi A, Kiyokawa N, Iwakura M, Okura K, Sugawara K, Takahashi H, Sakata S, Satake M, Shioya T. Effects of low‐intensity exercise and home‐based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with COPD [abstract]. European Respiratory Journal 2015;46:PA3563.
    1. Kawagoshi A, Kiyokawa N, Sugawara K, Takahashi H, Sakata S, Satake M, et al. Effects of low‐intensity exercise and home‐based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with chronic obstructive pulmonary disease. Respiratory Medicine 2015;109(3):364‐71.
Larson 2014 {published data only (unpublished sought but not used)}
    1. Covey MK, McAuley E, Kapella MC, Collins EG, Alex CG, Berbaum ML, et al. Upper‐body resistance training and self‐efficacy enhancement in COPD. Journal of Pulmonary and Respiratory Medicine 2012;Suppl 9:001.
    1. Larson JL, Covey MK, Kapella MC, Alex CG, McAuley E. Self‐efficacy enhancing intervention increases light physical activity in people with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 2014;9:1081‐90.
Loeckx 2018 {published data only}
    1. Loeckx M, Rodrigues F, Demeyer H, Janssens W, Troosters T. Improving physical activity to obtain sustainable benefits in extra‐pulmonary consequences of COPD after pulmonary rehabilitation: a randomized controlled trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A2452.
Lord 2012 {published data only (unpublished sought but not used)}
    1. Lord VM, Hume VJ, Kelly JL, Cave P, Silver J, Waldman M, et al. Effects of 'singing for breathing' in patients with chronic obstructive pulmonary disease (COPD) ‐ a randomized controlled trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2012;185:A5788.
    1. Lord VM, Hume VJ, Kelly JL, Cave P, Silver J, Waldman M, et al. Singing classes for chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulmonary Medicine 2012;12:69.
Louvaris 2016 {published and unpublished data}
    1. Kortianou E, Louvaris Z, Spetsioti S, Vasilopoulou M, Chynkiamis N, Nasis I, et al. High‐intensity interval exercise training improves daily physical activity levels in COPD [abstract]. European Respiratory Journal 2014;44(Suppl 58):1709.
    1. Louvaris Z, Spetsioti S, Kortianou EA, Vasilopoulou M, Nasis I, Kaltsakas G, et al. Aerobic interval training induces clinically meaningful effects in daily physical activity in COPD [abstract]. European Respiratory Journal 2016;48:PA2053.
    1. Louvaris Z, Spetsioti S, Kortianou EA, Vasilopoulou M, Nasis I, Kaltsakas G, et al. Interval training induces clinically meaningful effects in daily activity levels in COPD. European Respiratory Journal 2016;48(2):567‐70.
Maddocks 2016 {published data only}
    1. Maddocks M, Nolan CM, Man WD, Polkey MI, Hart N, Gao W, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double‐blind, placebo‐controlled trial. Lancet Respiratory Medicine 2016;4(1):27‐36.
Magnussen 2017 {published and unpublished data}
    1. Magnussen H, Arzt M, Andrea S, Plate T, Ribera A, Seoane B, et al. Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study. European Respiratory Journal 2017;49(6):1700485.
    1. Magnussen H, Arzt M, Andreas S, Plate T, Ribera A, Seoane B, et al. The effect of aclidinium bromide 400µg on lung function, sleep quality and physical activity in patients with chronic obstructive pulmonary disease: results of a phase IV pilot study [abstract]. American Journal of Respiratory and Critical Care Medicine 2016;193:A6820.
    1. Magnussen H, Arzt M, Andreas S, Plate T, Ribera A, Seoane B, et al. The effect of aclidinium bromide 400µg on sleep quality in COPD: a pilot study [abstract]. European Respiratory Journal 2016;48:PA4051.
Mantoani 2018 {published data only}
    1. Mantoani L, McKinstry B, McNarry S, Mullen S, Begg S, Saini P, et al. Physical activity enhancing programme (PAEP) in COPD – a randomised controlled trial [abstract]. European Respiratory Journal 2018;52(Suppl 62):OA1986.
Mendoza 2015 {published data only}
    1. Mendoza L, Aguilera M, Balmaceda N, Espinoza J, Horta P, Castro A, et al. Effect of a program of physical activity enhancement using pedometers in patients with chronic obstructive pulmonary disease [abstract]. American Journal of Respiratory and Critical Care Medicine 2013;187:A1360.
    1. Mendoza L, Aguilera M, Espinoza J, Balmaceda N, Horta P, Castro A, et al. Effects of a program of physical activity encouragement using pedometers in COPD patients [abstract]. European Respiratory Journal 2013;45(2):A570.
    1. Mendoza L, Horta P, Espinoza J, Aguilera M, Balmaceda N, Castro A, et al. Pedometers to enhance physical activity in COPD: a randomised controlled trial. European Respiratory Journal 2015;45(2):347‐54.
Mitchell 2013 {published and unpublished data}
    1. Mitchell KE, Johnson‐Warrington V, Apps LD, Bankart J, Sewell L, Williams JE, et al. A self‐management programme for COPD: a randomised controlled trial. European Respiratory Journal 2014;44(6):1538‐47.
    1. Mitchell KE, Warrington V, Sewell L, Bankart J, Williams JE, Steiner MC, et al. A randomised controlled trial of a self‐management programme of activity coping and education ‐ SPACE for COPD: impact on physical activity at 6 weeks [abstract]. American Journal of Respiratory and Critical Care Medicine 2013;187:A5952.
    1. Mitchell‐Wagg K, Warrington V, Apps L, Sewell L, Bankart J, Steiner MC, et al. A self‐management programme of activity coping and education (SPACE) for COPD: results from a randomised controlled trial [abstract]. Thorax 2012;67(Suppl 2):A25.
    1. Wagg K, Warrington V, Apps L, Sewell L, Bankart J, Steiner M, et al. A self‐management programme of activity coping and education (SPACE) for COPD: 6 week results from a randomised controlled trial [abstract]. European Respiratory Journal 2012;40(Suppl 56):548s.
    1. Wagg K, Wilcock E, Williams J, Sewell L, Steiner MC, Morgan M, et al. Pulmonary rehabilitation using the space (a self management programme of activity, coping and education) manual at home: a randomised controlled trial [abstract]. Thorax 2009;64:A97.
Moy 2015a {published data only}
    1. Martinez CH, Moy ML, Nguyen HQ, Cohen M, Kadri R, Roman P, et al. Taking healthy steps: rationale, design and baseline characteristics of a randomized trial of a pedometer‐based internet‐mediated walking program in veterans with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 2014;14:12.
    1. Moy ML, Collins RJ, Martinez CH, Kadri R, Roman P, Holleman RG, et al. An internet‐mediated pedometer‐based program improves health‐related quality‐of‐life domains and daily step counts in COPD: a randomized controlled trial. Chest 2015;148(1):128‐37.
    1. Moy ML, Collins RJ, Martinez CH, Kadri R, Roman P, Holleman RG, et al. An internet‐mediated, pedometer‐based walking program improves HRQOL in veterans with COPD [abstract]. American Journal of Respiratory and Critical Care Medicine 2014;189:A3642.
    1. Moy ML, Martinez CH, Kadri R, Roman P, Holleman RG, Kim HM, et al. Long‐term effects of an internet‐mediated pedometer‐based walking program for chronic obstructive pulmonary disease: randomized controlled trial. Journal of Medical Internet Research 2016;18(8):e215.
    1. Moy ML, Martinez CH, Kadri R, Roman P, Holleman RG, Kim HM, et al. Long‐term effects of an internet‐mediated pedometer‐based walking program in COPD: a randomized controlled trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2015;191:A2457.
Nakamura 2016 {published data only}
    1. Nakamura H, Mori Y, Nanki N, Kamei T. Clinical benefits of aclidinium bromide twice daily compared with tiotropium once daily in patients with moderate to severe chronic obstructive pulmonary disease [abstract]. American Journal of Respiratory and Critical Care Medicine 2017;195:A5471.
NCT00144326 {published data only}
    1. García Río F. A randomised, double‐blind, placebo‐controlled, 12 weeks trial to evaluate the effect of tiotropium inhalation capsules on the magnitude of exercise, measured using an accelerometer, in patients with chronic obstructive pulmonary disease. Boehringer Ingelheim Trial Results 2007; Vol. Trial number 205.269 (first received 5 September 2005).
NCT01351792 {published data only}
    1. NCT01351792. Multicentre, randomized research study to test the safety and efficacy of Foster® compared to Symbicort® on small airway function in patients with COPD. Chiesi Clinical Study Report (first received 11 May 2011). [Study number CCD‐1007‐PR‐0045]
Ng 2015 {published and unpublished data}
    1. Ng LW, Jenkins S, Cecins N, Eastwood P, Hill K. A wheeled walker improves physical activity in chronic obstructive pulmonary disease [abstract]. Physiotherapy 2015;101:eS1084.
    1. Ng LW, Jenkins S, Cecins N, Eastwood P, Hill K. The effect of using a wheeled walker on physical activity in people with COPD: preliminary data [abstract]. Respirology 2012;17(Suppl 1):60.
Nguyen 2009 {published data only}
    1. Estrada EL, Silva K, Medina E, Desai S, Fan VS, Nguyen HQ. Depression and anxiety are associated with COPD patients' lower confidence for increasing physical activity but not with their motivation [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A7066.
    1. Lee JS, Liu AI, Pounds D, Mahmud F, Flores C, Desai SA, et al. Characteristics of COPD patients who agree to participate in a pragmatic trial of physical activity coaching compared to non‐participants [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A2642.
    1. Mahmud F, Valmonte F, Medina E, Pounds D, Nguyen HQ. Real‐world implementation of a physical activity coaching program [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A2728.
    1. Nguyen HQ, Gill DP, Wolpin S, Steele BG, Benditt JO. Pilot study of a cell phone‐based exercise persistence intervention post‐rehabilitation for COPD. International Journal of Chronic Obstructive Pulmonary Disease 2009;4:301‐13.
Nolan 2017 {published and unpublished data}
    1. Nolan CM, Maddocks M, Canavan JL, Jones SE, Delogu V, Kaliaraju D, et al. Pedometer step count targets during pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized controlled trial. American Journal of Respiratory and Critical Care Medicine 2017;195(10):1344‐52.
    1. Nolan CM, Maddocks M, Canavan JL, Jones SE, Delogu V, Kaliaraju D, et al. Pedometer step count targets during pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized controlled trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2016;193:A7862.
    1. Nolan CM, Maddocks M, Canavan JL, Jones SE, Kon SS, Kaliaraju D, et al. Do pedometers maintain the benefits of pulmonary rehabilitation in COPD patients? [abstract]. European Respiratory Journal 2016;48:PA2058.
O'Neill 2018 {published data only}
    1. O'Neill B, O'Shea OM, McDonough SM, McGarvey L, Bradbury I, Arden MA, et al. Physical activity intervention versus pulmonary rehabilitation in COPD: the LIVELY COPD project [abstract]. Thorax 2016;71(Suppl 3):A20.
    1. O’Neill B, O’Shea OM, McDonough SM, McGarvey L, Bradbury I, Arden MA, et al. Clinician‐facilitated physical activity intervention versus pulmonary rehabilitation for improving physical activity in COPD: a feasibility study. COPD: Journal of Chronic Obstructive Pulmonary Disease 2018;15(3):254‐64.
Ogasawara 2018 {published data only}
    1. Ogasawara T, Marui S, Miura E, Sugiura M, Matsuyama W, Aoshima Y, et al. Effect of eicosapentaenoic acid on prevention of lean body mass depletion in patients with exacerbation of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Clinical Nutrition ESPEN 2018;28:67‐73.
Orme 2018 {published data only}
    1. Orme MW, Weedon AE, Esliger DW, Saukko PM, Morgan MD, Steiner MC, et al. Study protocol for Chronic Obstructive Pulmonary Disease‐Sitting and ExacerbAtions Trial (COPD‐SEAT): a randomised controlled feasibility trial of a home‐based self‐monitoring sedentary behaviour intervention [protocol]. BMJ Open 2016;6:e013014.
    1. Orme MW, Weedon AE, Saukko PM, Esliger DW, Morgan MD, Steiner MC, et al. Findings of the Chronic Obstructive Pulmonary Disease ‐ Sitting and Exacerbations Trial (COPD‐SEAT) in reducing time using wearable and mobile technologies with educational support: randomized controlled feasibility trial. JMIR mHealth and uHealth 2018;6(4):e84.
Polkey 2018 {published data only}
    1. Polkey MI, Qiu ZH, Zhou L, Zhu MD, Wu YX, Chen YY, et al. Tai Chi and pulmonary rehabilitation compared for treatment‐naïve patients with COPD; a randomized controlled trial. Chest 2018;153(3):1116‐24.
Priori 2017 {published and unpublished data}
    1. Priori R, Genugten L, Barretto C, Schonenberg H, Stut W, Miller B, et al. Automated coaching for physical activity in COPD patients: results from a pilot study [abstract]. European Respiratory Journal 2017;50:OA4868.
    1. Saini PK, Dekker M, Van Genugten, Prior R, Klee M. Online coaching for physical activity in COPD patients: user engagement and determinants [abstract]. European Respiratory Journal 2018;52:PA3644.
    1. Genugten L, Priori R, Barretto C, Schonenberg H, Dekker M, Klee M, et al. An online intervention to maintain physical activity levels in COPD patients after pulmonary rehabilitation [abstract]. Bulletin of the European Health Psychology Society 2016;18:635.
Probst 2011 {published data only}
    1. Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F. Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respiratory Care 2011;56(11):1799‐807.
Rinaldo 2017 {published data only}
    1. Rinaldo N, Bacchi E, Coratella G, Vitali F, Milanese C, Rossi A, et al. Effects of combined aerobic‐strength training vs fitness education program in COPD patients. International Journal of Sports Medicine 2017;38(13):1001‐8.
Saini 2017 {published data only}
    1. Saini PK, Dekker M, Genugten L, Priori R, Klee M. Online coaching for physical activity in COPD patients: user engagement and determinants [abstract]. European Respiratory Journal 2018;52(Suppl 62):PA3644.
    1. Saini PK, Priori R, Barretto C, Delbressine J, Genugten L, Dekker M, et al. Activity maintenance after pulmonary rehabilitation ‐ first results of an online coaching program [abstract]. American Journal of Respiratory and Critical Care Medicine 2017;195:A4942.
    1. Genugten L, Prior R, Barretto C, Schonenberg H, Dekker M, Klee M, et al. An online intervention to maintain physical activity levels after pulmonary rehabilitation [abstract]. European Health Psychologist 2016; Vol. 18.
Sandland 2008 {published data only}
    1. Sandland CJ, Morgan MD, Singh SJ. Patterns of domestic activity and ambulatory oxygen usage in COPD. Chest 2008;134(4):753‐60.
Schuz 2015 {published and unpublished data}
    1. Schuz N, Walters JA, Cameron‐Tucker H, Scott J, Wood‐Baker R, Walters EH. Patient anxiety and depression moderate the effects of increased self‐management knowledge on physical activity: a secondary analysis of a randomised controlled trail on health‐mentoring in COPD. Journal of Chronic Obstructive Pulmonary Disease 2015;12(5):502‐9.
    1. Walters JA, Cameron‐Tucker H, Wills K, Schuz N, Scott J, Robinson A, et al. Effects of telephone health mentoring in community‐recruited chronic obstructive pulmonary disease on self‐management capacity, quality of life and psychological morbidity: a randomised controlled trial. BMJ Open 2013;3(9):e003097.
    1. Walters JA, Wills K, Robinson A, Nelson M, Scott J, Turner P, et al. Effect of health‐mentoring to increase daily physical activity in chronic obstructive pulmonary disease (COPD) [abstract]. Respirology 2012;17:TP079.
Sena 2013 {published and unpublished data}
    1. Sena R, Baril J, Kapchinsky S, MacMillan NJ, Rocha DV, Ruddy R, et al. The effects of eccentric and concentric exercise training on muscle strength in COPD: preliminary results [abstract]. European Respiratory Journal 2012;40(Suppl 56):P482.
    1. Sena R, MacMillan NJ, Baril J, Rocha V, Richard R, Perrault H, et al. Short term effects of eccentric and concentric exercise training on strength muscle, exercise capacity and physical activity in patients with chronic obstructive pulmonary disease [abstract]. Canadian Respiratory Journal 2013;20(2):e36.
Singh 1998 {published data only (unpublished sought but not used)}
    1. Singh SJ, Curcio A, Williams J, Morgan MD, Jones P. Does wearing an activity monitor influence daily activity recorded in patients with COPD? [abstract]. Thorax 1998;53(Suppl 4):A24.
Steele 2019 {published data only}
    1. Kang Y, Steele BG, Burr RL, Dougherty CM. Mortality in advanced chronic obstructive pulmonary disease and heart failure following cardiopulmonary rehabilitation. Biological Research for Nursing 2018;20(4):429‐39.
    1. Steele BG, Dougherty CM, Burr RL, Gylys‐Colwell I, Hunziker J. A feasibility trial of two rehabilitation models in severe cardiopulmonary illness. Rehabilitation Nursing 2019;44(3):130‐40.
    1. Steele BG, Dougherty CM, Burr RL, Gylys‐Colwell I, Hunziker J. An intervention to enhance function in severe cardiopulmonary illness [abstract]. American Journal of Respiratory and Critical Care Medicine 2012;185:A4879.
Tabak 2014a {published data only}
    1. Tabak M, Vollenbroek‐Hutten MM, Valk PD, Palen H, Hermens HJ. A telerehabilitation intervention for patients with chronic obstructive pulmonary disease: a randomized controlled pilot trial. Clinical Rehabilitation 2014;28(6):582‐91.
Tabak 2014b {published data only}
    1. Tabak M, Brusse‐Keizer M, Valk P, Hermens H, Vollenbroek‐Hutten M. A telehealth program for self‐management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial. International Journal of Chronic Obstructive Pulmonary Disease 2014;9:935‐44.
Tahirah 2015 {published and unpublished data}
    1. Tahirah F, Jenkins S, Othman SK, Ismail R, Ismail T, Hill K. A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) [abstract]. European Respiratory Journal 2015;46:PA743.
Troosters 2014 {published data only (unpublished sought but not used)}
    1. Sciurba FC, Siafakas NM, Troosters T, Klioze SS, Sutradhar SC, Weisman IM, et al. The efficacy and safety of tiotropium handihaler 18 micrograms once daily plus prn salbutamol versus placebo plus prn salbutamol in COPD subjects naive to maintenance therapy [abstract]. American Journal of Respiratory and Critical Care Medicine 2011;183:A1589.
    1. Troosters T, Sciurba FC, Decramer M, Siafakas NM, Klioze SS, Sutradhar SC, et al. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo‐controlled trial. Primary Care Respiratory Medicine 2014;24:14003.
    1. Troosters T, Weisman I, Dobbels F, Giardino N, Valluri SR. Assessing the impact of tiotropium on lung function and physical activity in GOLD stage II COPD patients who are naïve to maintenance respiratory therapy: a study protocol. Open Respiratory Medicine Journal 2011;5:1‐9.
Troosters 2018 {published data only}
    1. Bourbeau J, Lavoie KL, Sedano M, Sousa D, Erzen D, Hamilton A, et al. Behaviour‐change intervention in a multicentre, randomised, placebo‐controlled COPD study: methodological considerations and implementation [protocol]. BMJ Open 2016;6:e010109.
    1. Bourbeau J, Sedeno M, Li PZ, Troosters T, Hamilton A, Sousa D, et al. Impact of meeting behavioral targets in a self‐management behaviour‐modification program designed to improve physical activity in COPD patients [abstract]. European Respiratory Journal 2017;50:PA4899.
    1. Frith P, Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, et al. Effect of tiotropium and olodaterol, alone and with exercise training, on exercise endurance in COPD [abstract]. Respirology 2017;22(Suppl 2):TO048.
    1. Frith P, Troosters T, Lavoie KL, Leidy N, Maltais F, Sedeno M, et al. Bronchodilator therapy and exercise added to self‐management behaviour‐modifications: effects on physical activity in COPD [abstract]. Respirology 2017;22(Suppl 2):TO129.
    1. Lavoie KL, Sedeno M, Li PZ, Troosters T, Hamilton A, Sousa D, et al. Effects of bronchodilator therapy and exercise with self‐management behaviour‐modification on psychological and cognitive outcomes in COPD [abstract]. European Respiratory Journal 2017;50:OA4669.
    1. Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, Sousa D, et al. Effect of 8 and 12 weeks' once‐daily tiotropium and olodaterol alone and combined with exercise training, on exercise endurance during walking in patients with COPD [abstract]. European Respiratory Journal 2016;48:PA976.
    1. Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, Sousa D, et al. Effect of 8 and 12 weeks' once‐daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD [abstract]. Thorax 2016;71(Suppl 3):A21‐22.
    1. Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, Sousa D, et al. Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non‐pharmacological interventions: PHYSACTO randomised, placebo‐controlled study design [protocol]. BMJ Open 2016;6:e010106.
    1. Troosters T, Lavoie KL, Leidy N, Maltais F, Sedeno M, Janssens W, et al. Effects of bronchodilator therapy and exercise training, added to a self‐management behaviour‐modification programme, on physical activity in COPD [abstract]. European Respiratory Journal 2016;48:PA713.
    1. Troosters T, Lavoie KL, Leidy N, Maltais F, Sedeno M, Janssens W, et al. Effects of bronchodilator therapy and exercise training, added to a self‐management behaviour‐modification programme, on physical activity in COPD [abstract]. Pneumonologie 2017;71(S01):37.
    1. Troosters T, Maltais F, Leidy N, Lavoie KL, Sedeno M, Janssens A, et al. Effect of bronchodilation and exercise training with behavior modification on exercise tolerance and downstream effects on symptoms and physical activity in COPD. American Journal of Respiratory and Critical Care Medicine 2018;198(8):1021‐32.
Tsai 2016 {published and unpublished data}
    1. Tsai LL, McNamara RJ, Moddel C, Alison JA, McKenzie D, McKeogh ZJ. Home‐based telerehabilitation via real‐time videoconferencing improves endurance exercise capacity in patients with COPD: the randomized controlled TeleR study. Respirology 2017;22(4):699‐707.
    1. Tsai LL, McNamara RJ, Moddel C, Alison JA, McKenzie DK, McKeough ZJ. Home‐based telerehabilitation via real‐time videoconferencing improves endurance exercise capacity in patients with COPD: the randomized controlled TeleR sStudy [abstract]. Respirology 2016;21(S2):TP086.
    1. Tsai LL, McNamara RJ, Moddel C, McKenzie D, Alison JA, McKeough ZJ. Telerehabilitation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial [abstract]. European Respiratory Journal 2016;48(Suppl 60):PA2065.
Van de Bool 2017 {published data only}
    1. Beers M, Rutten‐van Molken MP, Bool C, Boland M, Kremers SP, Franssen FM, et al. Clinical outcome and cost‐effectiveness of 1‐year nutritional intervention program in COPD [abstract]. European Respiratory Journal 2018;52(Suppl 62):PA723.
    1. Beers M, Rutten‐van Molken MP, Bool C, Boland M, Kremers SP, Franssen FM, et al. Clinical outcome and cost‐effectiveness of a 1‐year nutritional intervention programme in COPD patients with low muscle mass: the randomized controlled NUTRAIN trial. Clinical Nutrition 2019;39(2):405‐13.
    1. Bool C, Rutten EP, Helvoort A, Franssen FM, Wouters EF, Schols AM. A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD. Journal of Cachexia, Sarcopenia and Muscle 2017;8(5):748‐58.
    1. Bool C, Helvoort A, Franssen FM, Wouters EF, Schols AM. Physiological effects of nutritional supplementation as adjunct to exercise training in COPD patients with low muscle mass. The double blind, placebo controlled multi‐centre NUTRAIN‐trial [abstract]. European Respiratory Journal 2016;48(Suppl 60):OA266.
Varas 2018 {published and unpublished data}
    1. Varas AB, Cordoba S, Rodriguez‐Andonaegui I, Rueda MR, Garcia‐Juez S, Vilaro J. Effectiveness of a community‐based exercise training programme to increase physical activity level in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Physiotherapy Research International 2018;23(4):e1740.
Vasilopoulou 2017 {published and unpublished data}
    1. Vasilopoulou M, Papaioannou AI, Chynkiamis N, Vasilogiannakopoulou T, Spetsioti S, Louvaris Z, et al. Effectiveness of home telerehabilitation on functional capacity and daily physical activity in COPD patients [abstract]. European Respiratory Journal 2015;46:OA273.
    1. Vasilopoulou M, Papaioannou AI, Kaltsakas G, Louvaris Z, Chynkiamis N, Spetsioti S, et al. Home‐based maintenance tele‐rehabilitation reduces the risk of acute exacerbations of COPD, hospitalisations and emergency department visits. European Respiratory Journal 2017;49(5):pii:1602129.
Vorrink 2016 {published data only}
    1. Vorrink S, Huisman C, Kort H, Troosters T, Lammers JW. Perceptions of patients with chronic obstructive pulmonary disease and their physiotherapists regarding the use of an ehealth intervention. JMIR Human Factors 2017;4(3):e20.
    1. Vorrink SN, Kort HS, Troosters T, Zanen P, Lammers JL. Efficacy of an mHealth intervention to stimulate physical activity in COPD patients after pulmonary rehabilitation. European Respiratory Journal 2016;48(4):1019‐29.
Wan 2017 {published and unpublished data}
    1. Kantorowski A, Wan ES, Homsy D, Kadri R, Richardson CR, Moy ML. Determinants and outcomes of change in physical activity in COPD. ERJ Open Research 2018;4(3):pii: 00054‐2018.
    1. Robinson SA, Shimada SL, Quigley KS, Moy ML. A web‐based physical activity intervention benefits persons with low self‐efficacy in COPD: results from a randomized controlled trial. Journal of Behavioral Medicine 2019;42(6):1082‐90.
    1. Wan ES, Kantorowski A, Homsy D, Kadri R, Richardson CR, Mori D, et al. Self‐reported task‐oriented physical activity: a comparison with objective daily step count in COPD. Respiratory Medicine 2018;140:63‐70.
    1. Wan ES, Kantorowski A, Homsy D, Teylan M, Kadri R, Richardson CR, et al. Promoting physical activity in COPD: insights from a randomized trial of a web‐based intervention and pedometer use. Respiratory Medicine 2017;130:102‐10.
    1. Wan ES, Kantorowski A, Teylan M, Kadri R, Richardson CR, Garshick E, et al. Patterns of change in daily step count among COPD patients enrolled in a 3‐month physical activity intervention [abstract]. American Journal of Respiratory and Critical Care Medicine 2017;195:A4939.
Watz 2016 {published and unpublished data}
    1. Watz H, Mailaender C, Kirsten AM. Effects of indacaterol/glycopyrronium on lung function and physical activity in patients with moderate to severe COPD [abstract]. Thorax 2015;70:A146‐7.
    1. Watz H, Mailander C, Baier M, Kirsten AM. Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo‐controlled, crossover study (The MOVE Study). BMC Pulmonary Medicine 2016;16(1):95.
Watz 2017 {published data only}
    1. Watz H, Troosters T, Beeh KM, Garcia Aymerich J, Paggiaro P, Molins E, et al. ACTIVATE: effect of aclidinium/formoterol on physical activity in patients with COPD [abstract]. European Respiratory Journal 2017;60(Suppl 61):PA687.
    1. Watz H, Troosters T, Beeh KM, Garcia Aymerich J, Paggiaro P, Molins E, et al. Effect of aclidinium/formoterol on lung hyperinflation, exercise capacity and physical activity in patients with COPD: results from ACTIVATE, a phase IV study [abstract]. American Journal of Respiratory and Critical Care Medicine 2017;195:A3593.
    1. Watz H, Troosters T, Beeh KM, Garcia‐Aymerich J, Paggiaro P, Molins E, et al. ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity and physical activity in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 2017;12:2545‐58.
Widyastuti 2018 {published data only}
    1. Widyastuti K, Makhabah DN, Rima A, Sutanto YS, Suradi S, Ambrosino N. Home based pulmonary rehabilitation with pedometers in Indonesian COPD patients [abstract]. European Respiratory Journal 2017;50:PA777.
    1. Widyastuti K, Makhabah DN, Rima Setijadi A, Sutanto YS, Suradi S, Ambrosino N. Benefits and costs of home pedometer assisted physical activity in patients with COPD: a preliminary randomized controlled trial. Pulmonology 2018;24(4):211‐8.
Wootton 2017 {published and unpublished data}
    1. Hill K, Wootton SL, Ng LW, Jenkins S, Cecins N, Straker L, et al. High‐intensity ground‐based walking does not change time spent in physical activity or sedentary behaviour in people with chronic obstructive pulmonary disease [abstract]. Respirology 2016;21(Suppl 2):TP083.
    1. Watts SL, Ng LW, McKeogh ZJ, Jenkins S, Hill K, Eastwood PR, et al. Effects of ground walking training in COPD: a randomized controlled trial [abstract]. Respirology 2013;18(Suppl 2):O064.
    1. Wootton SL, Hill K, Alison JA, Ng LW, Jenkins S, Eastwood PR, et al. Effects of ground‐based walking training on daily physical activity in people with COPD: a randomised controlled trial. Respiratory Medicine 2017;132:139‐45.
    1. Wootton SL, Hill K, Alison JA, Ng LW, Jenkins S, Eastwood PR, et al. Effects of ongoing feedback during a 12‐month maintenance walking program on daily physical activity in people with COPD. Lung 2019;197(3):315‐9.
    1. Wootton SL, Ng LW, McKeough ZJ, Jenkins S, Hill K, Eastwood PR, et al. Ground walking training in chronic obstructive pulmonary disease: a randomised controlled trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2014;189:A4162.
    1. Wootton SL, Ng LW, McKeough ZJ, Jenkins S, Hill K, Eastwood PR, et al. Ground‐based walking training improves quality of life and exercise capacity in COPD. European Respiratory Journal 2014;44(4):885‐94.
References to studies excluded from this review ACTRN12611001034921 {published data only}
    1. ACTRN12611001034921. A randomised controlled clinical trial in adults with Chronic Obstructive Pulmonary Disease on the effect of telephone health‐mentoring, home‐based walking and rehabilitation compared with rehabilitation only on health‐related quality of life. (first received 29 November 2011).
Aksu 2006 {published data only}
    1. Aksu B, Inanir M, Basyigit I, Dursun N, Yildiz F. Comparison of two different exercise programs in chronic obstructive pulmonary disease [abstract]. European Respiratory Journal 2006;28(Suppl 50):555s.
Arnedillo 1998 {published data only}
    1. Arnedillo A, Puente L, Mangas A, Leaan A. Comparison of two exercise training programmes in patients with chronic obstructive pulmonary disease [abstract]. Neumosur 1998;10(4):223‐9.
Atkins 1984 {published data only}
    1. Atkins CJ, Kaplan RM, Timms RM, Reinsch S, Lofback K. Behavioral exercise programs in the management of chronic obstructive pulmonary disease. Journal of Consulting and Clinical Psychology 1984;52(4):591‐603.
Barnes‐Harris 2019 {published data only}
    1. Barnes‐Harris M, Allgar V, Booth S, Currow D, Hart S, Phillips J, et al. Battery operated fan and chronic breathlessness: does it help?. BMJ Supportive and Palliative Care 2019;May 8:pii: bmjspcare‐2018‐001749.
Bartlett 2017 {published data only}
    1. Bartlett YK, Webb TL, Hawley MS. Using persuasive technology to increase physical activity in people with chronic obstructive pulmonary disease by encouraging regular walking: a mixed‐methods study exploring opinions and preferences. Journal of Medical Internet Research 2017;19(4):e124.
Baumann 2006 {published data only}
    1. Baumann HJ, Rummel K, Schmoller T, Meyer A. Efficacy of a long term ambulatory interdisciplinary rehabilitation (AIR) program in moderate to severe COPD [abstract]. European Respiratory Journal 2006;28(Suppl 50):555s.
Behnke 2000 {published data only}
    1. Behnke M. The effects of a home‐based exercise training programme in patients with chronic obstructive lung disease. Pneumologie 2000;53:2‐3.
Behnke 2005 {published data only}
    1. Behnke M, Wewel AR, Kirsten D, Jorres RA, Magnussen H. Exercise training raises daily activity stronger than predicted from exercise capacity in patients with COPD. Respiratory Medicine 2005;99(6):711‐7.
Bernardi 2017 {published data only}
    1. Bernardi E, Merlo C, Bellotti F, Grazzi G, Cogo A. An exercise training program improves endothelial function in COPD patients [abstract]. European Respiratory Journal 2017;50(Suppl 61):OA1959.
Bertici 2013 {published data only}
    1. Bertici N, Fira‐Mladinescu O, Oancea C, Tudorache V. The usefulness of pedometry in patients with chronic obstructive pulmonary disease. Multidisciplinary Respiratory Medicine 2013;8(1):7.
Biscione 2009 {published data only}
    1. Biscione G, Crigna G, Auciello L, Pasqua F, Cazzola M. Addition of tiotropium (T) to a regular treatment with long‐acting beta‐agonist + inhaled corticosteroid (LABA + ICS) in patients with severe to very‐severe COPD under in‐patient pulmonary rehabilitation program (PRP) [abstract]. European Respiratory Society 19th Annual Congress; 2009 Sep 12‐15; Vienna. 2009:P526.
Bohning 1990 {published data only}
    1. Bohning W, Wettengel R. Physical exercise training in COPD during a 4 ‐week rehabilitation programme [abstract]. European Respiratory Journal 1990;3(Suppl 10):212S.
Boland 2015 {published data only}
    1. Boland MR, Tsiachristas A, Rutten van Molken M. COPD performance indicators in an integrated care program and its impact on health outcomes: The Recode Cluster Randomized Trial [abstract]. Value in Health 2015;18(7):A505.
    1. Kruis AL, Boland MR, Assendelft WJ, Gussekloo J, Tsiachristas A, Stijnen T, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: Results of cluster randomised trial. BMJ 2014;349(7976):g5392.
Börekçi 2008 {published data only}
    1. Börekçi S, Elci A, Ovayolu N, Elbeck O. Applicability and efficacy of the pulmonary rehabilitation program for COPD patients in a secondary‐care community hospital [Abstract]. American Thoracic Society International Conference; 2008 May 16‐21; Toronto. 2008; Vol. 5, issue 5:P416.
Borges 2012 {published data only}
    1. Borges RC, Carvalho CR. Physical activity in daily life in Brazilian COPD patients during and after exacerbation. Chronic Obstructive Pulmonary Disease 2012;9(6):596‐602.
Bourbeau 2000 {published data only}
    1. Bourbeau J, Julien M, Rouleau M, Maltais F, Beaupre A, Begin R, et al. Impact of an integrated rehabilitative self‐management program on health status of COPD patients: a multicentre randomised clinical trial [abstract]. European Respiratory Journal 2000;16(Suppl 31):159s.
Budnevskiy 2015 {published data only}
    1. Budnevskiy AV, Chernov AV, Isaeva YV, Yu Malysh E. Clinical efficacy of pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease and metabolic syndrome. Pulmonologiya 2015;25(4):447‐55.
Bunker 2012 {published data only}
    1. Bunker JM, Reddel HK, Dennis SM, Middleton S, Schayck C, Crockett AJ, et al. A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse‐general practitioner teams: study protocol. Implementation Science 2012;7:83.
Bustamante 2013 {published data only}
    1. Bustamante V, Lopez de Santamaria E, Marina N, Gorostiza A, Fernandez Z, Galdiz J. Neuromuscular magnetic stimulation of the quadriceps muscle after COPD exacerbations. European Respiratory Journal 2013;42:P3572.
Camillo 2011 {published data only}
    1. Camillo CA, Laburu V de M, Gonçalves NS, Cavalheri V, Tomasi FP, Hernandes NA, et al. Improvement of heart rate variability after exercise training and its predictors in COPD. Respiratory Medicine 2011;105(7):1054‐62.
Cebollero 2018 {published data only}
    1. Cebollero P, Anton M, Hernandez M, Hueto J. Walking program for COPD patients: clinical impact after two years of follow‐up [Programa de paseos para pacientes con EPOC: impacto clínico tras 2 anos de seguimiento]. Archivos de Bronconeumología 2018;54(8):431‐3.
    1. Hernandez Bonaga M, Zambom F, Cascante JA, Hueto J, Anton M, Cebollero Rivas P. Walking guide for COPD patients: a promoter of physical activity?. European Respiratory Journal 2014;44:p3681.
    1. Hernandez M, Zambom F, Cascante JA, Hueto J, Anton M, Cebollero P. Walking guide for COPD patients: can be used as a promoter of physical activity?. European Respiratory Journal 2013;42:p3703.
    1. Hernandez M, Zambom‐Ferraresi F, Milagros Anton M, Hueto J, Cascante J, Cebollero P. Short and long term effects of a physical activity programa in COPD patients. European Respiratory Journal 2015;46(Suppl 59):PA 2213.
Chen 2018 {published data only}
    1. Chen K‐Y, Hung M‐H, Chang M‐C, Kuo C, Lin C‐M, Chuang L‐P, et al. Four‐weeks remote pulmonary rehabilitation protocol with mobile apps of real‐time heart rate monitoring for gold category B/C/D‐A study design. Respirology 2018;23(Suppl 2):82.
Corrado 1995 {published data only}
    1. Corrado A, Gorini M, Paola E, Martorana P, Villella G, Augustynen A, et al. Effects of a short outpatient pulmonary rehabilitation program (PRP) in severe COPD patients with chronic respiratory insufficiency (CRI) [abstract]. European Respiratory Journal 1995;8(Suppl 19):126s.
Coultas 2011 {published data only}
    1. Coultas D, Sloan J, Wilson D. Pilot study of effectiveness of home rehabilitation for homebound patients with severe COPD [abstract]. European Respiratory Society 21st Annual Congress; 2011 Sep 24‐28; Amsterdam. 2011:881s.
Coultas 2017 {published data only}
    1. Ashmore J, Russo R, Peoples J, Sloan J, Jackson BE, Bae S, et al. Chronic obstructive pulmonary disease self‐management activation research trial (COPD‐SMART): design and methods. Contemporary Clinical Trials 2013;35(2):77‐86.
    1. Coultas D, Russo R, Peoples J, Ashmore J, Sloan J, Jackson B, et al. A lifestyle physical activity intervention is associated with decline in health care utilization (HCU) among patients with COPD [abstract]. European Respiratory Journal 2014;44(Suppl 58):P611.
    1. Coultas DB, Jackson BE, Russo R, Peoples J, Singh KP, Sloan J, et al. Home‐based physical activity coaching, physical activity, and healthcare utilization in COPD: COPD‐SMART secondary outcomes. Annals of the American Thoracic Society 2018;15(4):470‐8.
    1. Russo R, Coultas D, Ashmore J, Peoples J, Sloan J, Jackson BE, et al. Chronic obstructive pulmonary disease self‐management activation research trial (COPD‐SMART): results of recruitment and baseline patient characteristics. Contemporary Clinical Trials 2015;41C:192‐201.
De Backer 2014 {published data only}
    1. Backer W, Vos W, Holsbeke C, Vinchurkar S, Claes R, Hufkens A, et al. The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients [abstract]. European Respiratory Journal 2014;44(2):527‐9.
Deering 2011 {published data only}
    1. Deering BM, Fullen B, Egan C, McCormack N, Kelly E, Pender M, et al. Acupuncture as an adjunct to pulmonary rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 2011;31(6):392‐9.
De Souza 2017 {published data only}
    1. Souza Y, Sliva KM, Condesso D, Figueira B, Alves RR, Costa CH, et al. Home‐based pulmonary rehabilitation intervention: does it maintain the benefits achieved during the outpatient program [abstract]. American Journal of Respiratory and Critical Care Medicine 2017;195:A941.
Durheim 2015 {published data only}
    1. Durheim MT, Smith PJ, Babyak MA, Mabe SK, Emery CF, Blumenthal JA, et al. Physical function as measured by 6‐minute walk distance or accelerometry predicts clinical outcomes in COPD patients independent of GOLD 2011 [abstract]. American Journal of Respiratory and Critical Care Medicine 2014;189:A6679.
    1. Durheim MT, Smith PJ, Babyak MA, Mabe SK, Martinu T, Welty‐Wolf KE, et al. Six‐minute‐walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Annals of the American Thoracic Society 2015;12(3):349‐56.
Dyer 2011 {published data only}
    1. Dyer F, Flude L, Bazari F, Jolley C, Englebretsen C, Lai D, et al. Non‐invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease. BMC Pulmonary Medicine 2011;11:58.
EUCTR2016‐003675‐21‐ES {published data only}
    1. EUCTR2016‐003675‐21‐ES. A study to test different doses of Danirixin in patients with COPD. (first received 18 April 2017).
Faulkner 2010 {published data only}
    1. Faulkner J, Walshaw E, Campbell J, Jones R, Taylor R, Price D, et al. The feasibility of recruiting patients with early COPD to a pilot trial assessing the effects of a physical activity intervention. Primary Care Respiratory Journal 2010;19(2):124‐30.
Fernandez 1998 {published data only}
    1. Fernandez J, Martin M, Moreno LF. Evaluation of a home‐based rehabilitation program controlled with pulse‐meter in COPD. Neumosur 1998;10(1):54‐5.
Foy 2006 {published data only}
    1. Foy CG, Wickley KL, Adair N, Lang W, Miller ME, Rejeski WJ, et al. The Reconditioning Exercise and Chronic Obstructive Pulmonary Disease Trial II (REACT II): Rationale and study design for a clinical trial of physical activity among individuals with chronic obstructive pulmonary disease. Contemporary Clinical Trials 2006;27(2):135‐46.
Friis 2017 {published data only}
    1. Friis AL, Steenholt CB, Lokke A, Hansen M. Dietary beetroot juice ‐ effects on physical performance in COPD patients: a randomized controlled crossover trial. International Journal of Chronic Obstructive Pulmonary Disease 2017;12:1765‐73.
Furness 2014 {published data only}
    1. Furness T, Joseph C, Naughton G, Welsh L, Lorenzen C. Benefits of whole‐body vibration to people with COPD: a community‐based efficacy trial. BMC Pulmonary Medicine 2014;14(1):38.
Garcia Aymerich 2016 {published data only}
    1. Garcia Aymerich J, Puham M, Jongh C, Demeyer H, Erzen D, Gimeno Santos E, et al. Responsiveness of PROactive instruments to measure physical activity in COPD patients [abstract]. European Respiratory Journal 2016;48:PA1896.
Gohl 2004 {published data only}
    1. Gohl O, Linz H, Otte B, Schonleben T, Weineck J, Worth H. Benefits of a multicomponent outpatient rehabilitation program for patients with chronic obstructive pulmonary disease [abstract]. American Thoracic Society 100th International conference; 2004 May 21‐26; Orlando. 2004:D14.
    1. Gohl O, Linz H, Otte B, Schonleben T, Weineck J, Worth H. Effects of multicomponent outpatient rehabilitation program for patients with COPD [abstract]. European Respiratory Journal 2004;24(Suppl 48):208s.
Gohl 2006 {published data only}
    1. Gohl O, Schacher C, Grensemann S, Worth H. Effects of inspiratory muscle training with the RESPIFIT S in addition to an outpatient exercise training program for patients with COPD [abstract]. European Respiratory Journal 2006;28(Suppl 50):556s.
Gomez 2006 {published data only}
    1. Gomez A, Roman M, Larraz C, Esteva M, Mir I, Thomas V, et al. Efficacy of respiratory rehabilitation on patients with moderate COPD in primary care and maintenance of benefits at 2 years. Atencion Primaria / Sociedad Espanola de Medicina de Familia y Comunitaria 2006;38(4):230‐3.
Gosselink 1990 {published data only}
    1. Gosselink H, Keimpema A, Wagenaar R, Chadwick Straver R. The relative efficacy of a rehabilitation‐programme in COPD patients [abstract]. European Respiratory Journal 1990;10(Suppl 10):212S.
Grabenhorst 2013 {published data only}
    1. Grabenhorst M, Jehn M, Maldener N, Liebers U, Kohler F, Witt C. Telemedicine in patients with COPD: Feasibility and benefit of regular exercise testing via remote patient monitoring [abstract]. Pneumologie 2013;67:P377.
Greulich 2013 {published data only}
    1. Greulich T, Augsten M, Kehr K, Nell C, Koehler U, Werner J. A randomized clinical trial to assess the influence of a three months training program (individualized vs. non‐individualized) in patients with moderate to very severe COPD [abstract]. American Journal of Respiratory and Critical Care Medicine 2012;185:A4874.
    1. Greulich T, Kehr K, Nell C, Haid D, Koehler U, Koehler K, et al. A randomized clinical trial comparing the influence of two different training modalities (individualized vs. non‐individualized) in patients with moderate to very severe COPD [abstract]. American Journal of Respiratory and Critical Care Medicine 2013;187:A1801.
Guell 2008 {published data only}
    1. Guell MR, Lucas P, Galdiz JB, Montemayor T, Gonzalez‐Moro JM, Gorostiza A, et al. Home versus hospital‐based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a Spanish multicenter trial. Archivos de Bronconeumología 2008;44(10):512‐8.
    1. Guell R, Delucas P, Galdiz JB, Montemayor T, Rodriguez JM, Gorostiza A, et al. Effectiveness of a home based pulmonary rehabilitation program compared to a hospital based pulmonary rehabilitation program in COPD patients, a Spanish multicenter randomized trial [abstract]. European Respiratory Journal 2006;28(Supp 50):298s.
Gurgun 2011 {published data only}
    1. Gurgun A, Tuncel S, Korkmaz Ekren P, Deniz PS, Karapolat H, Kayahan B. Efficacy of an eight‐week pulmonary rehabilitation in COPD patients: an experience of a single center in Turkey [abstract]. American Journal of Respiratory and Critical Care Medicine 2011;183:A5049.
Hartman 2012 {published data only}
    1. Hartman JE, Boezen M, Heintzbergen S, Greef MH, Klooster K, Hacken NH, et al. Daily physical activity after bronchoscopic lung volume reduction: a pilot study. European Respiratory Journal 2012;40:1566‐7.
Hataji 2017 {published data only}
    1. Hataji O, Nishii Y, Ito K, Sakaguchi T, Saiki H, Suzuki Y, et al. Smart watch‐based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine 2017;14(5):4061‐4.
Herrejon 2010 {published data only}
    1. Herrejon A, Catalan P, Palop J, Inchaurraga I, Blanquer R, Lopez A, et al. Effect of 8‐week 320 mg Megestrol acetate daily administration In severe COPD and weight loss [abstract]. American Journal of Respiratory and Critical Care Medicine 2010;181:A4484.
Hillegass 2012 {published data only}
    1. Hillegass E, Hayes D, Sanders D, Owens T, Langbehn C, Johnson M, et al. Continuous versus pulsed oxygen: is there a difference with activity? A pilot study [abstract]. Chest 2012;142(4):802A.
Horton 2018 {published data only}
    1. Horton EJ, Mitchell KE, Johnson‐Warrington V, Apps LD, Sewell L, Morgan M, et al. Comparison of a structured home‐based rehabilitation programme withe conventional supervised pulmonary rehabilitation: a randomised non‐inferiority trial. Thorax 2018;73:29‐36.
Ichinose 2017 {published data only}
    1. Ichinose M, Minakata Y, Motegi T, Ueki J, Gon Y, Seki T. Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activityet al. International Journal of Chronic Obstructive Pulmonary Disease 2018;13:1407‐19.
    1. Ichinose M, Minakata Y, Motegi T, Ueki J, Gon Y, Seki T, et al. Efficacy of tiotropium/olodaterol on lung hyperinflation, exercise capacity, and physical activity in Japanese patients with Chronic Obstructive Pulmonary Disease (VESUTO Study): a randomized crossover trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A4243.
    1. Ichinose M, Minakata Y, Motegi T, Ueki J, Seki T, Anzai T, et al. Study design of VESUTO: efficacy of tiotropium/olodaterol on lung hyperinflation, exercise capacity and physical activity in Japanese patients with chronic obstructive pulmonary disease. Advances in Therapy 2017;34(7):1622‐35.
    1. Ichinose M, Minakata Y, Motegi T, Ueki J, Seki T, Anzai T, et al. Study design of VESUTO; study to evaluate the efficacy of tiotropium + olodaterol vs tiotropium on lung hyperinflation, exercise capacity, and physical activity in Japanese COPD patients [abstract]. Respirology 2016;21(S3):APSR6‐0457.
    1. Minakata Y, Motegi T, Ueki J, Gon Y, Seki T, Anzai T, et al. Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study [abstract]. European Respiratory Journal 2018;52(Suppl 62):PA4390.
Ides 2012 {published data only}
    1. Ides KM, Backer L, Daems D, Boelen E, Leemans G, Vissers D, et al. Preliminary results of noninvasive ventilation during a pulmonary rehabilitation program in patients with COPD [abstract]. European Respiratory Journal 2012;50(Suppl 56):639s.
Innocenti 2000 {published data only}
    1. Innocenti F, Fabbri A, Guerrini M, Fonseca D, Lippi P. Results of an outpatient pulmonary rehabilitation program in patients with COPD [abstract]. European Respiratory Journal 2000;16(Suppl 31):46s.
Johnson‐Warrington 2016 {published data only}
    1. Johnson‐Warrington V, Rees K, Gedler C, Morgan MD, Singh SJ. Can a supported self‐management program for COPD upon hospital discharge reduce readmissions? A randomized controlled trial. International Journal of Chronic Obstructive Pulmonary Disease 2016;11:1161‐9.
Jonsdottir 2015 {published data only}
    1. Jonsdottir H, Amundadottir OR, Gudmundsson G, Halldorsdottir BS, Hrafnkelsson B, Ingadottir TS, et al. Effectiveness of a partnership‐based self‐management programme for patients with mild and moderate chronic obstructive pulmonary disease: a pragmatic randomized controlled trial. Journal of Advanced Nursing 2015;71(11):2634‐49.
Kato 2017 {published data only}
    1. Kato D, Dobashi K, Fueki M, Tomioka S, Yamada H, Fueki N. Short‐term and long‐term effects of a self‐managed physical activity program using a pedometer for chronic respiratory disease: a randomized controlled trial. Journal of Physical Therapy Science 2017;89:807‐12.
Kim 2003 {published data only}
    1. Kim DS, Na JO, Jegal YJ, Yoon SH, Shim TS, Lim CM, et al. Efficacy of home based pulmonary rehabilitation program for the patients with chronic lung diseases [abstract]. European Respiratory Journal 2003;22(Suppl 45):A1082.
Kruis 2014 {published data only}
    1. Kruis AL, Boland MR, Assendelft WJ, Gussekloo J, Tsiachristas A, Stijnen T, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: Results of cluster randomised trial. BMJ Online 2014;349(7976):g5392.
Langer 2018 {published data only}
    1. Langer D, Ciavaglia C, Faisal A, Webb KA, Neder JA, Gosselink R, et al. Inspiratory muscle training reduces diaphragm activation and dyspnea during exercise in COPD. Journal of Applied Physiology 2018;125(2):381‐92.
Larraz 2010 {published data only}
    1. Larraz C, Esteva M, Ripoll J, Mir I, Gómez A, Román M. Efficacy of a rehabilitation program on moderate COPD conducted in primary care and the maintenance of benefits during two years [abstract]. Primary Care Respiratory Journal 2010;19(2):A22.
Lee 2007 {published data only}
    1. Lee KH, Shin KC, Chung JH, Yu SK. Effects of self‐efficacy promoting pulmonary rehabilitation program for chronic obstructive pulmonary disease patients [abstract]. American Thoracic Society International Conference; 2007 May 18‐23; San Francisco. 2007:M60.
Liang 2018 {published data only}
    1. Liang J, Abramson M, Zwar N, Russell G, Holland A, Bonevski B, et al. An interdisciplinary model of care for the early detection and management of chronic obstructive pulmonary disease (COPD) in primary care‐the RADICALS trial [abstract]. Respirology 2016;21(Suppl 2):61.
    1. Liang J, Abramson MJ, Zwar NA, Russell GM, Holland AE, Bonevski M, et al. Diagnosing COPD and supporting smoking cessation in general practice: evidence–practice gaps. Medical Journal of Australia 2018;208(1):29‐34.
Liu 2019 {published data only}
    1. Liu X, Li P, Xiao L, Lu Y, Li N, Wang Z, et al. Effects of home‐based prescribed pulmonary exercise by patients with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. Trials 2019;20(1):41.
Lum 2007 {published data only}
    1. Lum CM, Woo J, Yeung F, Hui DS, Hui E. Semi‐supervised, domiciliary pulmonary rehabilitation programme: a controlled clinical trial. Hong Kong Medical Journal 2007;13(Suppl 5):42‐5.
Mahesh 2017 {published data only}
    1. Mahesh PA, Srikanth JN, Ananthakrishna MS, Parthasarathi G, Chaya SK, Rajgopal R, et al. Amelioration of quality of life and lung function of chronic obstructive pulmonary disease by pranic healing as adjuvant therapy: a randomised double blind placebo controlled pilot study. Australasian Medical Journal 2017;10(8):665‐73.
Marques 2019 {published data only}
    1. Marques A, Jacome C, Rebelo P, Paixao C, Oliveira A, Cruz J, et al. Improving access to community‐based pulmonary rehabilitation: 3R protocol for real‐world settings with cost‐benefit analysis. BMC Public Health 2019;19(1):676.
Martinez 2008 {published data only}
    1. Martinez G, Thogersen J, Brondum E, Ringaek T, Lange P. Effect of maintenance training after 7 weeks rehabilitation programme [abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:E2805.
McGlone 2006 {published data only}
    1. McGlone S, Venn A, Walters EH, Wood‐Baker R. Physical activity, spirometry and quality‐of‐life in chronic obstructive pulmonary disease. COPD 2006;3(2):83‐8.
McMahon 2000 {published data only}
    1. McMahon S, Small T, Higgins BG, Corris PA. The use of a novel patient activity monitor to assess the therapeutic effect of adding salmeterol to regular therapy in patients with chronic obstructive pulmonary disease [abstract]. Thorax 2000;55(Suppl 3):A40.
Mesquita 2017 {published data only}
    1. Mesquita R, Meijer K, Pitta F, Azcuna H, Goertz YM, Essers JM, et al. Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD. Respiratory Medicine 2017;126:122‐9.
Moore 2009 {published data only}
    1. Moore R, Berlowitz D, Denehy L, Jackson B, McDonald CF. Comparison of pedometer and activity diary for measurement of physical activity in chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation and Prevention 2009;29(1):57‐61.
Morris 2012 {published data only}
    1. Atkinson C, Seale H, Walsh J, Adams L, Morris NR. The addition of a pedometer‐guided intervention to pulmonary rehabilitation fails to improve physical activity levels in individuals with COPD [abstract]. Respirology 2012;17(Suppl 1):64.
    1. Morris NR, Atkinson C, Seale H, Walsh J. The addition of a pedometer guided intervention to pulmonary rehabilitation [abstract]. American Journal of Respiratory and Critical Care Medicine 2012;185:A2383.
Moy 2009 {published data only}
    1. Moy ML, Matthess K, Stolzmann K, Reilly J, Garshick E. Free‐living physical activity in COPD: assessment with accelerometer and activity checklist. Journal of Rehabilitation Research and Development 2009;46(2):277‐86.
Moy 2012 {published data only}
    1. Moy ML, Weston NA, Wilson EJ, Hess ML, Richardson CR. A pilot study of an Internet walking program and pedometer in COPD. Respiratory Medicine 2012;106(9):1342‐50.
Murphy 2005 {published data only}
    1. Murphy MC, Campbell M, Saunders JE, Jackson B. A randomized trial to compare the outcomes of a pulmonary rehabilitation program (PRP) weekly maintenance and the Stanford Model Chronic Disease Self Management Program (CDSMP) in COPD [abstract]. American Thoracic Society International Conference; 2005 May 20‐25; San Diego. 2005:A26.
Nagata 2018 {published data only}
    1. Nagata K, Kikuchi T, Horie T, Shiraki A, Kitajima T, Kadowaki T, et al. Domiciliary high‐flow nasal cannula oxygen therapy for patients with stable hypercapnic Chronic Obstructive Pulmonary Disease. A multicenter randomized crossover trial. Annals of the American Thoracic Society 2018;15(4):422‐39.
    1. Nagata K, Kikuchi T, Horie T, Shiraki A, Kitajima T, Kadowaki T, et al. Domiciliary high‐flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial [abstract]. European Respiratory Journal 2017;50:OA4428.
NCT00620022 {published data only}
    1. O'Donnell D, Casaburi R, Vincken W, Puente‐Maestu L, Swales J, Lawrence D, et al. Effect of indacterol on exercise endurance and lung hyperinflation in COPD. Respiratory Medicine 2011;105(7):1030‐6.
NCT01012765 {published data only}
    1. Watz H, Krippner F, Kirsten A, Magnussen H, Vogelmeier C. Effects of indacaterol on lung volumes and physical activity In moderate chronic obstructive pulmonary disease [abstract]. American Journal of Respiratory and Critical Care Medicine 2012;185:A2257.
    1. Watz H, Krippner F, Kirsten A, Magnussen, Vogelmeier C. Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease ‐ a randomized, multicenter, double‐blind, placebo‐controlled study. BMC Pulmonary Medicine 2014;14(1):158.
NCT01380652 {published data only}
    1. NCT01380652. Effects of whole body vibration training on physical activity in Chronic Obstructive Pulmonary Disease (COPD) III/IV patients during a three‐week rehabilitation. (first received 27 June 2011).
NCT01486186 {published data only}
    1. Wang M, Li J, Li S, Wang H, Yu X, Zhang H. Effect of traditional Chinese medicine on outcomes in patients with mild/moderate chronic obstructive pulmonary disease: study protocol for a randomized placebo‐controlled trial. Trials 2012;13:109.
NCT01722370 {published data only}
    1. NCT01722370. Ambulatory oxygen effects on muscles in COPD (OM‐COPD). (first received 6 November 2012).
NCT01854008 {published data only}
    1. Pleguezuelos E, Pérez ME, Guirao L, Samitier B, Costea M, Ortega P, et al. Improving physical activity in patients with COPD with urban walking circuits. Respiratory Medicine 2013;107(12):1948‐56.
    1. Pleguezuelos E, Pérez ME, Guirao L, Samitier B, Costea M, Ortega P, et al. Improving physical activity in patients with severe COPD with urban walking circuits. A randomised trial [abstract]. European Respiratory Society Annual Congress; 2013 September 7‐11; Barcelona. 2013; Vol. 42, issue Suppl 57:302s.
NCT01867970 {published data only}
    1. Weegen S, Verwey R, Spreeuwenberg M, Tange H, Weijden T, Witte L. It's LiFe! Mobile and web‐based monitoring and feedback tool embedded in primary care increases physical activity: a cluster randomized trial. Journal of Medical Internet Research 2015;17(7):e184.
    1. Verwey R, Weegen S, Spreeuwenberg M, Tange H, Weijden T, Witte L. A monitoring and feedback tool embedded in a counselling protocol to increase physical activity of patients with COPD or type 2 diabetes in primary care: study protocol of a three‐arm cluster randomised controlled trial. BMC Family Practice 2014;15:93.
NCT01871025 {published data only}
    1. Rodriguez DA, Rodopin A, Guerrero M, Coll R, Huerta A, Soler N, et al. Impact of step exercises as an early intervention during COPD exaverbation [abstract]. European Respiratory Journal 2016;48:PA2061.
NCT02100709 {published data only}
    1. NCT02100709. The effect of NIV on QoL and exercise capacity in a COPD exercise rehabilitation program. (first received 27 March 2014).
NCT02172794 {published data only}
    1. NCT02172794. Tiotropium inhalation capsules and salmeterol inhalation aerosol on muscular efficiency and resting energy expenditure in patients with stable chronic obstructive pulmonary disease. (first received 24 June 2014).
NCT02629965 {published data only}
    1. NCT02629965. Comparing the efficacy of tiotropium + olodaterol fixed dose combination over tiotropium in improvement of lung hyperinflation, exercise capacity and physical activity in Japanese COPD patients. (first received 15 December 2015).
NCT02656667 {published data only}
    1. Vivodtzev I, Debigaré R, Gagnon P, Mainguy V, Saey D, Dubé A, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest 2012;141(3):716‐25. [DOI: 10.1378/chest.11-0839; NCT02656667]
NCT03751670 {published data only}
    1. NCT03751670. Pulmonary rehabilitation during acute exacerbations of Chronic Obstructive Pulmonary Disease: a mixed‐methods approach. (first received 23 November 2018).
NL1729 {published data only}
    1. NL1729. Effects of a phyisiotherapeutic exercise programme in patients with a combination of COPD and chronic heart failure: the CHEST‐study. (first received 2009).
Norweg 2006 {published data only}
    1. Norweg AM, Whiteson J, Malady R, Mola A, Rey M. The effectiveness of different combinations of pulmonary rehabilitation program components: a randomized controlled trial. Journal of Cardiopulmonary Rehabilitation 2006;26(2):120‐1.
Nyberg 2017 {published data only}
    1. Nyberg A, Wadell K, Lindgren H, Tistad M. Internet‐based support for self‐management strategies for people with COPD‐protocol for a controlled pragmatic pilot trial of effectiveness and a process evaluation in primary healthcare. BMJ Open 2017;7(7):e016851.
Paneroni 2016 {published data only}
    1. Paneroni M, Scalvini S, Bernocchi P, Galli T, Baratti D, Rovere MT, et al. Home telerehabilitation maintenance program for patients affected by COPD and CHF [abstract]. European Respiratory Journal 2016;48(Suppl 60):OA268.
Pasqua 2010 {published data only}
    1. Pasqua F, Biscione G, Crigna G, Auciello L, Cazzola M. Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: A pilot study. Respiratory Medicine 2010;104(3):412‐7.
Pinnock 2013 {published data only}
    1. Pinnock H, Hanley J, Lewis S, MacNee W, Pagliari C, Pol M, et al. The impact of a telemetric chronic obstructive pulmonary disease monitoring service: Randomised controlled trial with economic evaluation and nested qualitative study. Primary Care Respiratory Journal 2009;18(3):233‐5.
Pitta 2008 {published data only}
    1. Pitta F, Takaki MY, Oliveira NH, Sant'anna TJ, Fontana AD, Kovelis D, et al. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respiratory Medicine 2008;102(8):1203‐7.
Pomidori 2012 {published data only}
    1. Pomidori L, Contoli M, Mandolesi G, Cogo A. A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One‐year study. Journal of Cardiopulmonary Rehabilitation and Prevention 2012;32(1):53‐7.
Raphael 2014 {published data only}
    1. Raphael Y, Maynard Da Silva K, Bessa EJ, Bartholo TP, Faria AC, Noronha Filho AJ, et al. Brazilian manual of home‐based pulmonary rehabilitation: does it maintain the benefits achieved during the outpatient program? [abstract]. American Journal of Respiratory and Critical Care Medicine 2014;189:A1913.
Ringbaek 2009 {published data only}
    1. Ringbaek T, Broendum E, Martinez G, Thoegersen J, Lange P. Effect of maintenance training after 7‐weeks rehabilitation programme on hospitalisation [abstract]. European Respiratory Society 19th Annual Congress; 2009 Sep 12‐15; Vienna. 2009:P576.
Robbins 2000 {published data only}
    1. Robbins R. More evidence for the short‐term beneficial effects of lung volume reduction surgery. Critical Care 2002;2(1):6379.
Rodriguez‐Trigo 2011 {published data only}
    1. Rodriguez‐Trigo G, Cejudo P, Puy C, Galdiz JB, Bdeir K, Gorostiza A, et al. Long term pulmonary rehabilitation programs for chronic obstructive pulmonary disease (COPD). Two years follow‐up [abstract]. European Respiratory Journal 2011;38(55):655s.
Romagnoli 2005 {published data only}
    1. Romagnoli M, Dell'Orso D, Lubello R, Lucic S, Lugli D, Bellantone T, et al. Repeated pulmonary rehabilitation program (PRP) in severe and disabled COPD patients [abstract]. European Respiratory Journal 2005;26(Supp 49):A542.
Roman 2013 {published data only}
    1. Roman M, Larraz C, Gomez A, Ripoll J, Mir I, Miranda EZ, et al. Efficacy of pulmonary rehabilitation in patients with moderate chronic obstructive pulmonary disease: a randomized controlled trial. BMC Family Practice 2013;14(1):21.
Schacher 2006 {published data only}
    1. Schacher C, Dhein Y, Schoeffski O, Worth H. Comparison of two different exercise programs in chronic obstructive pulmonary disease [abstract]. European Respiratory Journal 2006;28(Suppl 50):555s.
Schönhofer 1997 {published data only}
    1. Schönhofer B, Ardes P, Geibel M, Köhler D, Jones PW. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. European Respiratory Journal 1997;10(12):2814‐9.
Senthilnathan 2018 {published data only}
    1. Senthilnathan CV, Abinaya P, Rajalaxmi V, Mohan Kumar G, Subramanian SS. Efficacy of physical training program on chronic obstructive pulmonary disease [abstract]. Biomedicine 2018;38(2):240.
Sewell 2005 {published data only}
    1. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Can individualized rehabilitation improve functional independence in elderly patients with COPD?. Chest 2005;128(3):1194‐200.
    1. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Goal directed pulmonary rehabilitation does not significantly improve health status and domestic function. European Respiratory Journal 2001;18(Suppl 33):187s.
Sewell 2010 {published data only}
    1. Sewell L, Singh SJ, Williams JE, Morgan MD. Seasonal variations affect physical activity and pulmonary rehabilitation outcomes. Journal of Cardiopulmonary Rehabilitation and Prevention 2010;30(5):329‐33.
Sirichana 2013 {published data only}
    1. Sirichana W, Moore‐Gillon CE, Patel MH, Taylor M, Storer TW, Cooperr CB. Daily physical activity in COPD: quantification by tri‐axial accelerometry [abstract]. American Journal of Respiratory and Critical Care Medicine 2013;187:A1361.
Soicher 2009 {published data only}
    1. Soicher JE. A longitudinal study of physical activity behaviour in chronic disease: the example of chronic obstructive pulmonary disease [dissertation]. Montreal: McGill University, Montreal, 2009.
Spencer 2012 {published data only}
    1. Spencer L, Mckeough Z, Alison J. Where are they now? Four years after the completion of a maintenance exercise programme in people with COPD [abstract]. Respirology 2012;17(Suppl 1):15.
Steele 2008 {published data only}
    1. Steele BG, Belza B, Cain KC, Coppersmith J, Lakshminarayan S, Howard J, et al. A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease. Archives of Physical Medicine and Rehabilitation 2008;89(3):404‐12.
    1. Steele BG, Belza B, Coppersmith J, Cain K, Howard J, Lakshminarayan S. Promoting activity and exercise in chronic lung disease: an intervention study [abstract]. American Journal of Respiratory and Critical Care Medicine 2005;191:A2007.
Strijbos 1991 {published data only}
    1. Strijbos JH, Koeter GH, Postma DS, Altena R. Reactivation of severe COPD patients. Long term results of a first line and a clinical rehabilitation program. Nederlands Tijdschrift Fysiotherapie 1991;101(4):105‐10.
Sutanto 2018 {published data only}
    1. Sutanto YS, Santi N, Makhabah DN, Aphridasari J, Kusumo H, Reviono R. Pedometer as a tool for quality of life improvement in COPD patients [abstract]. Respirology 2018;23(Suppl 2):244‐5.
TCTR20170214002 {published data only}
    1. TCTR20170214002. The effects of breathing with a positive expiratory pressure on physical activity in patients with Chronic Obstructive Pulmonary Disease. (first received 5 February 2017).
Troosters 2010 {published data only}
    1. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, et al. Physical inactivity in patients with COPD, a controlled multi‐center pilot‐study. Respiratory Medicine 2010;104(7):1005‐11.
Troosters 2011 {published data only}
    1. Troosters T, Sutradhar S, Sciurba FC, Klioze SS, Siafakas N, Yunis C, et al. Understanding physical activity in moderate COPD: results from a large, multicenter trial [abstract]. American Journal of Respiratory and Critical Care Medicine 2011;183:A3959.
Tse 2013 {published data only}
    1. Tse HN, Raiteri L, Wong KY, Yee KS, Ng LY, Wai KY, et al. High‐dose N‐acetylcysteine in stable COPD: the 1‐year, double‐blind, randomized, placebo‐controlled HIACE study. Chest 2013;144(1):106‐18.
Turnbull 2013 {published data only}
    1. Turnbull J, McDonnell L, Bott J, Prevost T, Davidson C. Physical exercise and ambulatory oxygen device preference in patients' with exertional hypoxemia: a multicentre RCT [abstract]. European Respiratory Journal 2013;42(Suppl 57):772s.
    1. Turnbull J, McDonnell L, Osman L, Bott J, Prevost T, Davidson AC. Patient activity levels and oxygen device preference: an RCT comparing refillable cylinders (HomefillTM) with usual ambulatory device [abstract]. Thorax 2012;67(Suppl 2):A83.
Turner‐Lawlor 2005 {published data only}
    1. Turner‐Lawlor PJ, Shiels K, Griffiths TL. Randomized controlled trial of an 18 session pulmonary rehabilitation program delivered over 6 or 18 weeks, clinical outcomes [abstract]. American Thoracic Society International Conference; 2005 May 20‐25; San Diego. 2005:C87.
U1111‐1169‐0718 {published data only}
    1. U1111‐1169‐0718. Effect of training in vibrating platform in subjects with Chronic Obstructive Pulmonary Disease. (first received 7 April 2015).
UMIN000001833 {published data only}
    1. Sakai K, Nakayama H, Hokari S, Suzuki R, Takiguchi A, Takada T, et al. The efficacy of the assistant use of short‐acting Beta2 stimulant procaterol on the daily activity in COPD patients: Niigata multicentre study [abstract]. European Respiratory Journal 2011;38:862.
Valenson 2016 {published data only}
    1. Valenson W, Valmonte F, Rodriguez O, Medina E, Lowrey M, Lew S, et al. Perceived barriers to physical activity in patients at high risk for COPD exacerbations. Chest 2016;150(4 Suppl 1):892A.
Voncken‐Brewster 2013 {published data only}
    1. Voncken‐Brewster V, Tange H, Vries H, Nagykaldi Z, Winkens B, Weijden T. A randomised controlled trial testing a web‐based, computer‐tailored self‐management intervention for people with or at risk for chronic obstructive pulmonary disease: a study protocol. BMC Public Health 2013;13:557.
    1. Voncken‐Brewster V, Tange H, Vries H, Nagykaldi Z, Winkens B, Weijden T. A randomized controlled trial evaluating the effectiveness of a web‐based, computer‐tailored self‐management intervention for people with or at risk for COPD. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:1061‐73.
Wilson 2015 {published data only}
    1. Wilson AM, Browne P, Olive S, Clark A, Galey P, Dix E, et al. The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomised controlled trial. BMJ Open 2015;5(3):e005921.
Zanini 2002 {published data only}
    1. Zanini A, Giorgetti G, Facchetti C, Mazzucchelli G, Conti S, Lucioni A, et al. Efficacy of a rehabilitation program based on circuit training in COPD subjects: A preliminary report [abstract]. American Journal of Respiratory and Critical Care Medicine 2002;165(Suppl 8):A738.
References to ongoing studies ACTRN12615000121561 {published data only}
    1. ACTRN12615000121561. Effect of opioids on outcomes of pulmonary rehabilitation. (first received 12 January 2015).
ACTRN 12616000360415 {published data only}
    1. Cox NS, McDonald CF, Alison JA, Mahal A, Wootton R, Hill CJ, et al. Telerehabilitation versus traditional centre‐based pulmonary rehabilitation for people with chronic respiratory disease: protocol for a randomised controlled trial. BMC Pulmonary Medicine 2018;18:71.
ACTRN12616001534471 {published data only}
    1. ACTRN12616001534471. A behaviour‐change intervention to reduce sedentary time in people with chronic obstructive pulmonary disease. (first received 3 Nov 2016).
    1. Cheng SW, Alison JA, Dennis S, Stamatakis E, Spencer LM, McNamara RJ, et al. A behaviour change intervention to reduce sedentary time in people with chronic obstructive pulmonary disease: a protocol for a randomised controlled trial. Journal of Physiotherapy 2017;63:182.
ACTRN12616001586404 {published data only}
    1. ACTRN12616001586404. Effect of a pulmonary rehabilitation program of 8 weeks duration compared to 12 weeks on exercise capacity in people with chronic obstructive pulmonary disease (PuRe Duration): a randomised controlled trial. (first received 16 November 2016).
ACTRN12617000242325 {published data only}
    1. ACTRN12617000242325. Tai Chi for people with chronic obstructive pulmonary disease (COPD). (first received 16 February 2017).
ACTRN12617000499381 {published data only}
    1. ACTRN12617000499381. Non drug interventions to reduce breathlessness in patients with chronic obstructive pulmonary disease (emphysema). (first received 6 April 2017).
ACTRN12617000653369 {published data only}
    1. ACTRN12617000653369. Effect of cognitive behaviour therapy on anxiety, depression and breathlessness in patients with chronic obstructive pulmonary disease. (first received 5 May 2017).
ANZCTR12611000292976 {published data only}
    1. ANZCTR12611000292976. Can changing the way people with chronic lung disease think about breathlessness improve and sustain health outcomes?. (first received 17 March 2011).
    1. Williams MT, John D, Cafarella P, Frith P. No additional benefit for 6MWT or HADS in combining cognitive behavioural therapy and pulmonary rehabilitation [abstract]. Respirology 2017;22(S2):TO050.
    1. Williams MT, Paquet C, John D, Cafarella P, Frith P. No additional benefits for pulmonary rehabilitation including cognitive behavioural therapy [abstract]. Respirology 2018;23(S1):TO131.
Beekman 2014 {published data only}
    1. Beekman E, Mesters I, Hendriks EJ, Muris JW, Wesseling G, Evers SM, et al. Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort‐nested randomised controlled trial [protocol]. BMC Pulmonary Medicine 2014;14(1):71.
ChiCTR1800017405 {published data only}
    1. ChiCTR1800017405. Effects of pulmonary rehabilitation prescription on COPD patients. (first received 28 July 2018).
DRKS00004931 {published data only}
    1. DRKS00004931. "Medical Vulnerability" Impact of hospital room cooling in vulnerable patients with lung disease during periods of extreme weather (UCaHS). (first received 26 April 2013).
DRKS00010777 {published data only}
    1. DRKS00010777. The influence of the maintenance of physical activity on mental health of patients with occupational lung diseases after an inpatient rehabilitation in the BG clinic of Falkenstein. (first received 15 December 2017).
EUCTR2006‐005534‐20‐GB {published data only}
    1. EUCTR2006‐005534‐20‐GB. Effect of erdosteine on inflammatory and oxidative biomarkers in sputum and exhaled breath in patients with COPD. (first received 29 November 2007).
EUCTR2013‐003619‐24‐ES {published data only}
    1. EUCTR2013‐003619‐24‐ES. Benefits of liquid oxygen in chronic obstructive pulmonary disease (COPD) patients without evidence of domiciliary oxygen therapy, presenting desaturation on exertion. (first received 13 December 2013).
EUCTR2016‐001238‐89‐ES {published data only}
    1. EUCTR2016‐001238‐89‐ES. Impact of iron replacement in patients with chronic obstructive pulmonary disease. (first received 20 April 2016).
EUCTR2016‐001805‐18‐SE {published data only}
    1. EUCTR2016‐001805‐18‐SE. A pilot study to explore safety and efficacy of NBMI treatment compared to placebo in patients with chronic obstructive pulmonary disease. (first received 19 May 2016).
Fastenau 2014 {published data only}
    1. Fastenau A. Exercise training and physical activity in patients with mild to moderate COPD in primary care [thesis]. Maastricht: Maastricht University, Maastricht, 2015.
    1. Fastenau A, Muris JW, Bie RA, Hendriks EJ, Asijee GM, Beekman E, et al. Efficacy of a physical exercise training programme COPD in primary care: study protocol of a randomized controlled trial. BMC Public Health 2014;14:788.
    1. Fastenau A, Schayck O, Winkens B, Gosselink R, Muris J. Effectiveness of a physical exercise training programme COPD in primary care: a randomized controlled trial [abstract]. European Respiratory Journal 2015;46:OA3287.
ISRCTN11017699 {published data only}
    1. ISRCTN11017699. Investigation of steroid responsiveness in patients with chronic obstructive pulmonary disease. (first received 15 November 2016).
ISRCTN13899108 {published data only}
    1. ISRCTN13899108. Can a physical activity programme or pulmonary rehabilitation reduce the risk of heart and circulation disease in people with COPD?. (first received 5 April 2019).
ISRCTN15949009 {published data only}
    1. ISRCTN15949009. Humidified nasal high flow to improve clinical outcomes following severe exacerbations of chronic obstructive pulmonary disease. (first received 19 February 2019).
ISRCTN17942821 {published data only}
    1. Bourne CL, Kanabar P, Mitchell K, Schreder S, Houchen‐Wolloff L, Bankart MJ, et al. A self‐management programme of activity coping and education ‐ SPACE for COPD(C) ‐ in primary care: the protocol for a pragmatic trial. BMJ Open 2017;7(7):e014463.
    1. ISRCTN17942821. A self‐management programme of activity coping and education ‐ SPACE FOR COPD ‐ in primary care: a pragmatic trial. (first received 17 November 2014).
ISRCTN19684749 {published data only}
    1. Buttery S, Kemp SV, Shah PL, Waller D, Jordan S, Lee JT, et al. CELEB trial: Comparative effectiveness of lung volume reduction surgery for emphysema and bronchoscopic lung volume reduction with valve placement: a protocol for a randomised controlled trial. BMJ Open 2018;8:e021368.
    1. ISRCTN19684749. CELEB: Lung volume reduction in COPD ‐ surgery vs endobronchial valves. (first received 23 May 2016).
ISRCTN27860457 {published data only}
    1. ISRCTN27860457. ON‐EPIC Oral nitrate supplementation to enhance pulmonary rehabilitation in chronic obstructive pulmonary disease. (first received 22 September 2014).
    1. Pavitt M, Lewis AP, Buttery SC, Fernandez BO, Mikus‐Lelinska M, Feelisch M, et al. Dietary nitrate supplementation increases exercise endurance time in COPD patients using ambulatory oxygen [abstract]. European Respiratory Journal 2018;52(Suppl 62):PA4049.
    1. Pavitt M, Tanner RJ, Lewis AP, Buttery SC, Mehta B, Jefford H, et al. Dietary nitrate supplementation enhances the benefit of pulmonary rehabilitation in people with COPD [abstract]. European Respiratory Journal 2018;52(Suppl 62):PA4045.
    1. Pavitt MJ, Tanner RJ, Lewis AP, Buttery SC, Mehta B, Jefford H, et al. Oral dietary nitrate supplementation to enhance pulmonary rehabilitation in chronic obstructive pulmonary disease: a multi‐centre, double blind, placebo‐controlled, parallel group study [abstract]. Thorax 2018;73(Suppl 4):A3.
ISRCTN45695543 {published data only}
    1. Daynes E, Greening N, Sidiqqui S, Singh SJ. A randomised controlled trial to investigate the use of high‐frequency airway oscillations as training to improve dyspnoea in COPD [protocol]. ERJ Open Research 2019;5:00064‐2019.
    1. ISRCTN45695543. Training to improve dyspnoea. (first received 15 February 2017).
ISRCTN80279999 {published data only}
    1. ISRCTN80279999. Domiciliary application of non‐invasive positive pressure ventilation with average volume assured pressure support to subjects with chronic obstructive pulmonary disease (COPD) who remain hypercapnic following the application of non‐invasive positive pressure ventilation (NPPV) for an acute exacerbation. (first received 11 December 2008).
NCT01037387 {published data only}
    1. NCT01037387. Effect of noninvasive ventilation on physical activity and inflammation in COPD patients. (first received 23 December 2009).
NCT01537627 {published data only}
    1. NCT01537627. Long‐term physical training in chronic obstructive pulmonary disease. (first received 23 February 2012).
NCT01539434 {published data only}
    1. NCT01539434. Behavioral intervention to maintain physical capacity and activity in patients with chronic obstructive pulmonary disease (COPD). (first received 27 February 2012).
NCT01783808 {published data only}
    1. NCT01783808. Intervention study to investigate supplemental oxygen in COPD. (first received 5 February 2013).
NCT01905982 {published data only}
    1. NCT01905982. The effect of reflective breathing therapy compared with conventional breathing therapy in patients with chronic obstructive pulmonary disease (COPD) III‐IV; part 2. (first received 23 July 2013).
NCT01998724 {published data only}
    1. Moy ML, Wayne PM, Litrownik D, Beach D, Klings ES, Davis RB, et al. Long‐term exercise after pulmonary rehabilitation (LEAP): design and rationale of a randomized controlled trial of Tai Chi. Contemporary Clinical Trials 2015;45(Part B):458‐67.
NCT02099799 {published data only}
    1. NCT02099799. The effect of physical activity promotion on short and long‐term outcomes in COPD (WEB). (first received 31 March 2014).
NCT02205242 {published data only}
    1. NCT02205242. BACE trial substudy 1 ‐ PROactive substudy. (first received 31 July 2014).
NCT02398643 {published data only}
    1. NCT02398643. Examine the impact of early education on COPD management. (first received 25 March 2015).
NCT02455206 {published data only}
    1. NCT02455206. Counseling during pulmonary rehabilitation. (first received 27 May 2015).
    1. Rausch‐Osthoff AK, Greco N, Schwank A, Beyer S, Gisi D, Scheermesser M, et al. Effect of counselling during pulmonary rehabilitation on self‐determined motivation towards physical activity in people with chronic obstructive pulmonary disease ‐ protocol of a mixed methods study. BMC Pulmonary Medicine 2017;17(1):115.
NCT02471235 {published data only}
    1. Ko FW, Chan K‐P, Tam W, Wong I, Chan TO, Ip A, et al. Short‐course pulmonary rehabilitation and exacerbations and activity of COPD patients over 1 year [abstract]. European Respiratory Journal 2018;52(Suppl 52):PA3353.
    1. NCT02471235. Short‐course out‐patient pulmonary rehabilitation and COPD exacerbations. (first received 15 June 2015).
NCT02478359 {published data only}
    1. Estrada EL, Silva K, Medina E, Desai S, Fan VS, Nguyen HQ. Depression and anxiety are associated with COPD patients' lower confidence for increasing physical activity but not with their motivation [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A7066.
    1. Lee JS, Liu AI, Pounds D, Mahmud F, Flores C, Desai SA, et al. Characteristics of COPD patients who agree to participate in a pragmatic trial of physical activity coaching compared to non‐participants [abstract]. American Journal of Respiratory and Critical Care Medicine 2018;197:A2642.
    1. NCT02478359. Walk on! Physical activity coaching. (first received 23 June 2015).
    1. Nguyen HQ, Bailey A, Coleman KJ, Desai S, Fan VS, Gould MK, et al. Patient‐centered physical activity coaching in COPD (Walk On!): a study protocol for a pragmatic randomized controlled trial. Contemporary Clinical Trials 2016;46:18‐29.
    1. Valenson W, Valmonte F, Rodriguez O, Medina E, Lowrey M, Lew S, et al. Perceived barriers to physical activity in patients at high risk for COPD exacerbations [abstract]. Chest 2016;150(4 Suppl 1):892A.
NCT02557178 {published data only}
    1. NCT02557178. Home‐based health management of COPD patients. (first received 23 September 2015).
NCT02667171 {published data only}
    1. Hansen H, Bieler T, Beyer N, Godtfredsen N, Kallemose T, Frolich A. COPD online‐rehabilitation versus conventional COPD rehabilitation ‐ rationale and design for a multicenter randomized controlled trial study protocol (CORe trial). BMC Pulmonary Medicine 2017;17:140.
    1. NCT02667171. COPD online rehabilitation (CORe) (CORe). (first received 28 January 2016).
NCT02691104 {published data only}
    1. NCT02691104. Use of the SMART COPD physical activity app in pulmonary rehabilitation. (first received 25 February 2016).
NCT02702791 {published data only}
    1. NCT02702791. Sustaining training effects through physical activity (STEP). (first received 9 March 2016).
NCT02707770 {published data only}
    1. NCT02707770. The role of ambulatory oxygen in improving the effectiveness of pulmonary rehabilitation for COPD patients. (first received 14 March 2016).
NCT02720822 {published data only}
    1. Currow D, Watts GJ, Johnson M, McDonald CF, Miners JO, Somogyi AA, et al. on behalf of the Australian National Palliative Care Clinical Studies Collaborative. A pragmatic, phase III, multisite, double‐blind, placebo‐controlled, parallel‐arm, dose increment randomised trial of regular, low‐dose extended‐release morphine for chronic breathlessness: breathlessness, exertion And morphine sulfate (BEAMS) study protocol. BMJ Open 2017;7(7):e018100.
    1. NCT02720822. Breathlessness exertion and morphine sulphate (BEAMS). (first received 28 March 2016).
NCT02864420 {published data only}
    1. Levine DM, Ouchi K, Blanchfield B, Diamond K, Licurse A, Pu CT, et al. Hospital‐level care at home for acutely ill adults: a pilot randomized controlled trial. Journal of General Internal Medicine 2018;33(5):729‐36.
    1. NCT02864420. Hospitalization at home: The acute care home hospital program for adults. (first received 12 August 2016).
NCT02895152 {published data only}
    1. NCT02895152. Activity monitor use in COPD patients undergoing rehabilitation. (first received 9 September 2016).
NCT02917915 {published data only}
    1. NCT02917915. The CaNadian Standardized Pulmonary Rehabilitation Efficacy trial (CoNSPiRE). (first received 28 September 2016).
    1. Selzler AM, Jourdain T, Sedeno M, Wald J, Janaudis‐Ferreira T, Goldstein R, et al. Development of the Canadian standardized pulmonary rehabilitation efficacy trial: a protocol update [abstract]. Canadian Journal of Respiratory Critical Care and Sleep Medicine 2017;1(3):170.
NCT02924870 {published data only}
    1. NCT02924870. Long‐term effect of an health education program on daily physical activity in patients with moderate to very severe chronic obstructive pulmonary disease (EA‐EPOC). (first received 5 October 2016).
NCT02956213 {published data only}
    1. NCT02956213. Indoor air quality and respiratory symptoms in former smokers. (first received 6 November 2016).
NCT02966561 {published data only}
    1. Geidl W, Semrau J, Streber R, Lehbert N, Wingart S, Tallner A, et al. Effects of a brief, pedometer‐based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6‐week and 6‐month objectively measured physical activity: study protocol for a randomized controlled trial. Trials 2017;18:396.
    1. NCT02966561. Pedometer‐based behavioural intervention for individuals with COPD to stay active after rehabilitation (STAR). (first received 17 November 2016).
NCT02999685 {published data only}
    1. Benzo RP, Kramer KM, Hoult JP, Anderson PM, Begue IM, Seifert SJ. Development and feasibility of a home pulmonary rehabilitation program with health coaching. Respiratory Care 2018;63(2):131‐40.
    1. NCT02999685. Home‐based health management of chronic obstructive lung Ddsease (COPD) patients. (first received 21 December 2016).
NCT03073954 {published data only}
    1. NCT03073954. Working memory training in COPD patients: the Cogtrain‐Trial. (first received 8 March 2017).
NCT03080662 {published data only}
    1. NCT03080662. Impact of inspiratory muscle training on daily physical activity (INAF). (first received 15 March 2017).
NCT03084874 {published data only}
    1. NCT03084874. Efficacy of a coaching program to promote physical activity and reduce sedentary behavior after a COPD hospitalization. (first received 21 March 2017).
NCT03114241 {published data only}
    1. NCT03114241. Long‐term effects of a 3‐month pedometer‐based program to enhance physical activity in patients with severe COPD. (first received 14 April 2017).
NCT03127878 {published data only}
    1. NCT03127878. Effects of upper‐limb training addition to a conventional ET program on PA level and ADL performance. (first received 25 April 2017).
NCT03201198 {published data only}
    1. NCT03201198. Active for life: chronic obstructive pulmonary disease (ActiveCOPD). (first received 28 June 2017).
NCT03275116 {published data only}
    1. NCT03275116. The effect of twice daily vs. once daily bronchodilation on hyperinflation in COPD patients during 24 hours (BOTH). (first received 7 September 2017).
NCT03280355 {published data only}
    1. NCT03280355. The effects of singing training for patients with chronic obstructive pulmonary disease. (first received 12 September 2017).
NCT03321279 {published data only}
    1. NCT03321279. Social incentives to increase mobility. (first received 25 October 2017).
NCT03359473 {published data only}
    1. NCT03359473. Study to evaluate the safety and efficacy of 13 weeks of the selective androgen receptor modulator (SARM) GSK2881078 in chronic obstructive pulmonary disease. (first received 2 December 2017).
NCT03513068 {published data only}
    1. NCT03513068. Portable oxygen concentrator improvements to physical activity, oxygen usage, and quality of life in chronic obstructive pulmonary disease patients using long‐term oxygen therapy (POC‐STEP). (first received 1 May 2018).
NCT03584269 {published data only}
    1. NCT03584269. Innovation in non invasive ventilation in COPD patients treated by long term oxygen therapy (INOV‐LTOT). (first received 12 July 2018).
NCT03584295 {published data only}
    1. NCT03584295. Early extubation by ECCO2R compared to IMV in patients with severe acute exacerbation of COPD (X‐COPD). (first received 12 July 2018).
NCT03620630 {published data only}
    1. NCT03620630. Clinical efficacy and cost effectiveness of MYCOPD in patients with mild and moderate newly diagnosed COPD (EARLY). (first received 8 August 2018).
NCT03654092 {published data only}
    1. Frei A, Radtke T, Lana KD, Braun J, Müller RM, Puhan MA. Effects of a long‐term home‐based exercise training programme using minimal equipment vs. usual care in COPD patients: a study protocol for two multicentre randomised controlled trials (HOMEX‐1 and HOMEX‐2 trials). BMC Pulmonary Medicine 2019;19:57.
NCT03655028 {published data only}
    1. NCT03655028. Increasing physical activity in COPD through rhythmically enhanced music. (first received 31 August 2018).
NCT03660644 {published data only}
    1. NCT03660644. Physical activity following pulmonary rehabilitation in COPD. (first received 6 September 2018).
NCT03746873 {published data only}
    1. NCT03746873. Increase level of physical activity and decrease use of health care for people with COPD. (first received 20 November 2018).
NCT03749655 {published data only}
    1. NCT03749655. Physical activity promotion added to standard care pulmonary rehabilitation and cognitive behavioural therapy. (first received 21 November 2018).
NCT03750292 {published data only}
    1. NCT03750292. Residential cleaning of indoor air to protect COPD patients (CARE). (first received 23 November 2018).
NCT03793192 {published data only}
    1. NCT03793192. Promoting activity after COPD exacerbations (aim 2, PACE2). (first received 4 January 2019).
NCT03794921 {published data only}
    1. NCT03794921. COPD access to pulmonary rehabilitation intervention (CAPRI). (first received 7 January 2019).
NCT03807310 {published data only}
    1. NCT03807310. Targeted nutrient supplement in COPD (NUTRECOVER‐trial). (first received 16 January 2019).
NCT03810755 {published data only}
    1. NCT03810755. EfiKroniK research program: physical exercise for people with chronic pathologies. (first received 22 January 2019).
NCT03817294 {published data only}
    1. NCT03817294. Personalised exercise training in COPD. (first received 25 January 2019).
NCT03869112 {published data only}
    1. NCT03869112. Physical activity intervention and cardiovascular risk markers in COPD (PARC). (first received 11 March 2019).
NCT03899558 {published data only}
    1. NCT03899558. The role of HNHF to improve clinical outcomes following severe AECOPD. (first received 2 April 2019).
NL3827 {published data only}
    1. NL3827. Pulmonary rehabilitation of COPD: a trial of sustained internet based self‐management support (PRACTISS COPD). (first received 27 May 2013).
NL5277 {published data only}
    1. NL5277. Efficacy of a physical activity coaching system for patients with COPD. (first received 30 October 2015).
RBR‐3zmh3r {published data only}
    1. RBR‐3zmh3r. Effects of the inclusion of a functional circuit to aerobic and resistance training on functionality, physical activity in daily life and inflammation of patients with chronic obstructive pulmonary disease. (first received 7 March 2018).
UMIN000027190 {published data only}
    1. UMIN000027190. The effect of the combination treatment with tiotropium and olodaterol compared to tiotropium on symptoms, respiratory functions and physical activity in maintenance naive Japanese patient with COPD. (first received 29 April 2017).
UMIN000031173 {published data only}
    1. UMIN000031173. Combined effect of progressive resistance training and physical activity counseling in patients with chronic obstructive pulmonary disease: a randomized controlled crossover study. (first received 26 February 2018).
UMIN000033093 {published data only}
    1. UMIN000033093. The effect of comprehensive respiratory rehabilitation using cloud system on exacerbation of patients with chronic obstructive pulmonary disease at home. (first received 1 July 2018).
Zanaboni 2016 {published data only}
    1. Zanaboni P, Dinesen B, Hjalmarsen A, Hoaas H, Holland AE, Oliveira CC, et al. Long‐term integrated telerehabilitation of COPD patients: A multicentre randomised controlled trial (iTrain) [protocol]. BMC Pulmonary Medicine 2016;16(1):126.
Additional references Adeloye 2015
    1. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: systematic review and meta‐analysis. Journal of Global Health 2015;5(2):020415.
Alahmari 2015
    1. Alahmari AD, Mackay AJ, Patel AR, Kowlessar BS, Singh R, Brill SE, et al. Influence of weather and atmospheric pollution on physical activity in patients with COPD. Respiratory Research 2015;16:71.
Andersson 2015
    1. Andersson M, Stridsman C, Ronmark E, Lindberg A, Emtner M. Physical activity and fatigue in chronic obstructive pulmonary disease ‐ a population based study. Respiratory Medicine 2015;109(8):1048‐57.
Anton 2016
    1. Anton A, Ratarasarn K. Pulmonary function testing and role of pulmonary rehabilitation in the elderly population with pulmonary diseases. Current Geriatric Reports 2016;5(2):117‐23.
Arne 2009
    1. Arne M, Janson C, Janson S, Boman G, Lindqvist U, Berne C, et al. Physical activity and quality of life in subjects with chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scandinavian Journal of Primary Health Care 2009;27(3):141‐7.
Casperson 1985
    1. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research. Public Health Reports 1985;100(2):126‐31.
Choudhury 2014
    1. Choudhury G, Rabinovich R, MacNee W. Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clinics in Chest Medicine 2014;35(1):101‐30.
Deeks 2017
    1. Deeks JJ, Higgins JP, Altman DG, editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking metaanalyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from .
Dhillon 2015
    1. Dhillon SS, Sima CA, Kirkham AR, Syed N, Camp PG. Physical activity measurement accuracy in individuals with chronic lung disease: a systematic review with meta‐analysis of method comparison studies. Archives of Physical Medicine and Rehabilitation 2015;96(11):2079‐88.e.10.
Esteban 2010
    1. Esteban C, Quintana JM, Aburto M, Moraza J, Equrrola M, Pérez‐Izquierdo J, et al. Impact of changes in physical activity on health‐related quality of life among patients with COPD. European Respiratory Journal 2010;36(2):292‐300.
Esteban 2014
    1. Esteban C, Arostequi I, Aburto M, Moraza J, Quintana JM, Aispiri S, et al. Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease. Respirology 2014;19(3):330‐8.
Fastenau 2013
    1. Fastenau A, Schayck OC, Gosselink R, Aretz KC, Muris JW. Discrepancy between functional exercise capacity and daily physical activity: a cross‐sectional study in patients with mild to moderate COPD. Primary Care Respiratory Journal 2013;22(4):425‐30.
Furlanetto 2010
    1. Furlanetto KC, Bisca GW, Oldemberg N, Sant'Anna TJ, Morakami FK, Camillo CA, et al. Step counting and energy expenditure estimation in patients with chronic obstructive pulmonary disease and healthy elderly: accuracy of 2 motion sensors. Archives of Physical Medicine and Rehabilitation 2010;91(2):261‐7.
Furlanetto 2014
    1. Furlanetto KC, Mantoani LC, Bisca G, Morita AA, Zabatiero J, Proença M, et al. Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction. Respirology 2014;19(3):69‐75.
Gagnon 2015
    1. Gagnon P, Casaburi R, Saey D, Porszasz J, Provencher S, Milot J, et al. Cluster analysis in patients with GOLD 1 chronic obstructive pulmonary disease. PLOS One 2015;10(4):e012362.
Garcia‐Aymerich 2006
    1. Garcia‐Aymerich J, Lange P, Benet M, Schohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61(9):772‐8.
Garcia‐Rio 2012
    1. Garcia‐Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012;142(2):338‐46.
Gimeno‐Santos 2011
    1. Gimeno‐Santos E, Frei A, Dobbels F, Rüdell K, Puhan MA, Garcia‐Aymerich J, et al. Validity of instruments to measure physical activity may be questionable due to a lack of conceptual frameworks: a systematic review. Health and Quality of Life Outcomes 2011;9:86.
GOLD 2019
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD 2019. (accessed 7 August 2019).
GRADEpro GDT 2014 [Computer program]
    1. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 29 September 2016. Hamilton (ON): McMaster University (developed by Evidence Prime), 2014.
Higgins 2017
    1. Higgins JP, Altman DG, Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from .
Hill 2013
    1. Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. European Respiratory Review 2013;22(129):405‐13.
Iwakura 2016
    1. Iwakura M, Okura K, Shibata K, Kawagoshi A, Sugawara K, Takahashi H, et al. Relationship between balance and physical activity measured by an activity monitor in elderly COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 2016;11:1505‐14.
Johnson‐Warrington 2014
    1. Johnson‐Warrington V, Harrison S, Mitchell K, Steiner M, Morgan M, Singh S. Exercise capacity and physical activity in patients with COPD and healthy subjects classified as Medical Research Council dyspnoea scale grade 2. Journal of Cardiopulmonary Rehabilitation and Prevention 2014;34(2):150‐4.
Lahham 2016
    1. Lahham A, McDonald CF, Holland AE. Exercise training alone or with the addition of activity counseling improves physical activity levels in COPD: a systematic review and meta‐analysis of randomized controlled trials. International Journal of COPD 2016;11:3121‐36.
Langer 2016
    1. Langer D, Demeyer H. Interventions to modify physical activity in patients with COPD: where do we go from here?. European Respiratory Journal 2016;48(1):14‐7.
Lee 2012
    1. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of physical inactivity on major non‐communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012;380(9838):219‐29.
Lee 2015
    1. Lee JA, Laurson KR. Validity of the SenseWear armband step count measure during controlled and free‐living conditions. Journal of Exercise Science and Fitness 2015;13(1):16‐23.
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from . The Cochrane Collaboration.
Mantoani 2016
    1. Mantoani LC, Rubio N, McKinstry B, Macnee W, Rabinovich PA. Interventions to modify physical activity in patients with COPD: a systematic review. European Respiratory Journal 2016;48(1):69‐81.
Marcus 2006
    1. Marcus BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK, et al. Physical activity intervention studies: what we know and what we need to know. A scientific statement from the American Heart Association Council on Nutrition, Physical Activity and Metabolism. Circulation 2006;114(24):2739‐52.
McCarthy 2015
    1. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD003793.pub3]
Michie 2013
    1. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy of 93 hierarchically clustered techniques: building an international consensus for the reporting of behaviour change interventions. Annals of Behavioral Medicine 2013;46(1):81‐95.
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman D, PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLOS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]
Nasis 2015
    1. Nasis I, Kortianou E, Vasilopoulou Μ, Spetsioti S, Louvaris Z, Kaltsakas G, et al. Hemodynamic effects of high intensity interval training in COPD patients exhibiting exercise‐induced dynamic hyperinflation. Respiratory Physiology and Neurobiology 2015;217:8‐16.
O’Donnell 2014
    1. O’Donnell DE, Laveneziana P, Webb K, Neder JA. Chronic obstructive pulmonary disease: clinical integrative physiology. Clinics in Chest Medicine 2014;35(1):51‐69.
Pitta 2005
    1. Pitta F, Troosters T, Spruit M, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005;171(9):972‐7.
Pitta 2006a
    1. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalisation for exacerbation of COPD. Chest 2006;129(3):536‐44.
Pitta 2006b
    1. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. European Respiratory Journal 2006;27(5):1040‐55.
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schünemann 2017
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Akl E, Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from .
Shrikrishna 2012
    1. Shrikrishna D, Patel M, Tabber RJ, Seymour JM, Connolly BA, Puthucheary ZA, et al. Quadriceps wasting and physical inactivity in patients with COPD. European Respiratory Journal 2012;40(5):1115‐22.
Singh 2016
    1. Singh S. One step at a time: lifestyle physical activity interventions. Annals of the American Thoracic Society 2016;13(5):586‐7.
Trost 2002
    1. Trost SG, Owen N, Cauman AE, Sallis JF, Brown W. Correlates of adults’ participation in physical activity: review and update. Medicine and Science in Sports and Exercise 2002;34(12):1996‐2001.
U.S. Department of Health and Human Services 2018
    1. U.S. Department of Health and Human Services. Physical activity guidelines for Americans, 2nd edition. Washington, DC 2018.
UN 2015
    1. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects. Key findings & advance tables. 2015 revision. (accessed 31 March 2020).
Vaes 2014
    1. Vaes AW, Garcia‐Aymerich J, Marott JL, Benet M, Groenen MT, Schnohr P, et al. Changes in physical activity and all‐cause mortality in COPD. European Respiratory Journal 2014;44(5):1199‐209.
Van Remoortel 2013
    1. Remoortel H, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, et al. Daily physical activity in subjects with newly diagnosed COPD. Thorax 2013;68(10):962‐3.
Van Remoortel 2014
    1. Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, et al. Risk factors and comorbidities in the preclinical stage of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2014;189(1):30‐8.
Vorrink 2011
    1. Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared to healthy controls. Respiratory Research 2011;12:33.
Waschki 2011
    1. Waschki B, Kirsten A, Holz O, Mueller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all‐cause mortality in patients with COPD: a prospective cohort study. Chest 2011;140(2):331‐42.
Waschki 2015
    1. Waschki B, Kirsten A, Holz O, Mueller KC, Schaper M, Sack AL, et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2015;192(3):295‐306.
Watz 2009
    1. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patient with COPD. European Respiratory Journal 2009;33(2):262‐72.
Watz 2014a
    1. Watz H, Pitta F, Rochester CL, Garcia‐Aymerich J, ZuWallack R, Troosters T, et al. An official European Respiratory Society statement on physical activity in COPD. European Respiratory Journal 2014;44(6):1521‐37.
WHO 2010
    1. World Health Organization. Global recommendations on physical activity for health. 2010. (accessed 29 September 2016).
WHO 2017
    1. World Health Organization. The top 10 causes of death (fact sheet 310). (accessed 30 March 2017).
References to other published versions of this review Burge 2017
    1. Burge AT, Cox NS, Abramson MJ, Holland AE. Interventions for promoting physical activity in people with COPD. Cochrane Database of Systematic Reviews 2017, Issue 4. [DOI: 10.1002/14651858.CD012626]

Source: PubMed

3
Abonneren